Obesity, other/unspecified

E4_OBESITYNAS

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.8, E66.9 Hospital discharge: ICD-9 — 2780 Hospital discharge: ICD-8 — 27799 Cause of death: ICD-10 — E66.8, E66.9 Cause of death: ICD-9 — 2780 Cause of death: ICD-8 — 27799 2 out of 7 registries used, show all original rules.	16487
4. Check minimum number of events None	16487
5. Include endpoints None	16487
6. Filter based on genotype QC (FinnGen only)	16487

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITYNAS
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66[8-9]
HD_ICD_9	2780
HD_ICD_8	27799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66[8-9]
COD_ICD_9	2780
COD_ICD_8	27799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	101521	63163	37539
Only index persons	87711	55646	32065
Unadjusted period prevalence (%)
Whole population	1.52	1.81	1.05
Only index persons	1.75	2.05	1.22
Median age at first event (years)
Whole population	48.13	47.17	49.69
Only index persons	46.49	45.16	48.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16487	11508	4979
Unadjusted period prevalence (%)	3.40	3.92	2.19
Median age at first event (years)	48.47	46.45	53.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14582: Matched controls
145829

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02AX02

ATC

tramadol; systemic, rectal

2.8

323.0

7294

38679

E66.01

ICD-10 Finland

Obesity due to excess calories

99.4

323.0

6103

1050

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.4

323.0

2258

7441

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

33.1

323.0

674

213

E66.9

ICD-10 Finland

Obesity, unspecified

355.2

323.0

5687

262

A10BX04

ATC

[U] exenatide; parenteral

25.8

323.0

522

209

T90

ICPC

Diabetes non-insulin dependent

4.3

323.0

4565

13933

J01DB01

ATC

cefalexin; oral

2.4

323.0

12403

101930

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

323.0

793

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

323.0

629

C08CA01

ATC

amlodipine; oral

2.2

323.0

4586

24850

A10BJ06

ATC

semaglutide; parenteral

10.8

323.0

1144

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

323.0

6173

36653

XG466

NOMESCO Finland

Sleep oxymetry

7.6

323.0

928

1298

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

12.4

323.0

1800

1634

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

323.0

5195

22976

R06.0

ICD-10 Finland

Dyspnoea

2.5

323.0

3900

18773

A10BJ02

ATC

liraglutide; parenteral

17.4

323.0

1046

644

T82

ICPC

Obesity

16.6

323.0

2062

1429

A46

ICD-10 Finland

Erysipelas

3.7

323.0

2600

8041

205

Kela drug reimbursment

Chronic hypertension

3.1

323.0

4108

16407

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.0

323.0

2443

9247

E66

ICD-10 Finland

Obesity

19.4

323.0

2661

1656

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

323.0

3022

13767

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.5

323.0

5187

15878

G47.3

ICD-10 Finland

Sleep apnoea

6.9

323.0

6296

14455

I50.9

ICD-10 Finland

Heart failure, unspecified

3.7

323.0

1729

5133

SPAT1262

SPAT

Handing over of treatment supplies

3.2

323.0

3224

11850

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

323.0

951

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

8651

57423

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

6.0

323.0

5349

12867

N02BE01

ATC

paracetamol; systemic, rectal

3.0

323.0

12947

105962

A10BH01

ATC

sitagliptin; oral

5.2

323.0

2043

4430

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

556.0

323.0

742

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

7.1

323.0

1097

1661

A02BC02

ATC

pantoprazole; systemic

2.3

323.0

9870

69681

J45.9

ICD-10 Finland

Asthma, unspecified

2.9

323.0

3287

13460

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.4

323.0

1906

3927

E66.8

ICD-10 Finland

Other obesity

913.8

323.0

9739

316

I10

ICD-10 Finland

Essential (primary) hypertension

3.3

323.0

8792

45919

162

Kela drug reimbursment

liraglutide

22.7

323.0

547

250

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.7

323.0

2865

9140

R4190

NOMESCO Finland

Nutritional therapy

10.0

323.0

1373

1499

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

10.1

323.0

2040

2321

103

Kela drug reimbursment

Diabetes, insulin-treated

4.8

323.0

5652

17113

A10AE04

ATC

insulin glargine; parenteral

4.0

323.0

1913

5293

M04AA01

ATC

allopurinol; systemic

3.9

323.0

2024

5830

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.3

323.0

1956

6538

C03CA01

ATC

furosemide; systemic

4.1

323.0

4756

15511

J01FF01

ATC

clindamycin; systemic

2.2

323.0

4491

24373

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.1

323.0

2571

7216

QBJ30

NOMESCO Finland

Correction of abdominal apron

52.9

323.0

687

136

R5140

NOMESCO Finland

Monitoring the use of the aid

6.2

323.0

3008

5828

160

Kela drug reimbursment

exenatide

23.7

323.0

1053

478

RD210

NOMESCO Finland

13.5

323.0

843

662

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.6

323.0

3926

18304

A10BA02

ATC

metformin; oral

6.1

323.0

6581

17377

E66.0

ICD-10 Finland

Obesity due to excess calories

499.1

323.0

670

C07AB07

ATC

bisoprolol; oral

2.1

323.0

6150

37425

A10BB12

ATC

glimepiride; oral

5.3

323.0

1317

2694

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

323.0

4919

25804

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.9

323.0

1605

4434

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

12.9

323.0

2020

1800

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6343.9

323.0

2209

A10BX07

ATC

[U] liraglutide; parenteral

25.0

323.0

635

265

WX722

NOMESCO Finland

PEEP

5.7

323.0

1062

1972

E66.00

ICD-10 Finland

Metabolic syndrome

42.5

323.0

3153

941

A10BK03

ATC

empagliflozin; oral

5.2

323.0

1606

3393

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.4

323.0

3194

8699

B01AB05

ATC

enoxaparin; parenteral

2.8

323.0

5320

24574

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

323.0

7216

47619

C03DA01

ATC

spironolactone; oral

3.4

321.6

1710

5410

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

3.0

318.1

2144

8033

H02AB06

ATC

prednisolone; systemic

2.0

316.9

6943

46144

N06AX16

ATC

venlafaxine; oral

2.6

313.6

2749

12075

A08AB01

ATC

orlistat; oral

35.4

307.5

403

117

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

300.2

2450

10302

N06AB03

ATC

fluoxetine; oral

2.7

300.1

2405

10006

C09AA02

ATC

enalapril; systemic

2.5

296.5

2681

11937

N03AX16

ATC

pregabalin; oral

2.2

293.2

3712

19535

N05AH04

ATC

quetiapine; oral

2.4

293.0

2940

13826

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.9

288.9

2034

7799

M79.6

ICD-10 Finland

Pain in limb

2.0

287.7

5440

33782

M54.5

ICD-10 Finland

Low back pain

2.0

280.9

5232

32221

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

280.9

2011

7783

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.0

278.2

1791

6465

N06AB04

ATC

citalopram; systemic

2.2

275.1

3573

18929

R60.0

ICD-10 Finland

Localized oedema

3.0

273.4

1768

6397

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

265.1

5726

37034

WX110

NOMESCO Finland

Local anesthesy

1.9

262.2

10365

82378

R4110

NOMESCO Finland

Physiotherapy

2.1

260.1

4005

22723

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

257.3

1371

4307

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.2

256.3

3040

15382

C10AA01

ATC

simvastatin; oral

1.9

256.1

4854

29824

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.9

250.6

1692

6276

J01DA01

ATC

[U] cefalexin; systemic

1.8

249.8

9359

72318

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

247.6

1890

7568

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

246.9

2807

13889

B03BA03

ATC

hydroxocobalamin; parenteral

4.2

245.6

1007

2529

J01AA02

ATC

doxycycline; systemic

1.9

238.9

11243

93060

N06AX21

ATC

duloxetine; oral

2.6

235.4

1986

8408

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.6

231.1

628

990

WX780

NOMESCO Finland

Remote monitoring CPAP

4.5

226.2

856

1985

L28

ICPC

Limited function/disability (L)

2.5

225.6

2099

9357

A10BK01

ATC

dapagliflozin; oral

4.4

225.2

873

2073

C03AA03

ATC

hydrochlorothiazide; oral

3.1

224.8

1389

4835

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.4

221.1

2251

10499

S97

ICPC

Chronic ulcer skin

4.2

220.3

904

2266

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.5

218.7

1947

8466

OAB72

NOMESCO Finland

Weight control and weight loss guidance

26.7

216.4

304

116

A10BJ01

ATC

exenatide; parenteral

16.6

215.0

353

217

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

213.5

2887

15314

S18

ICPC

Laceration/cut

1.8

212.7

5589

37769

I50.0

ICD-10 Finland

Congestive heart failure

4.1

211.5

877

2218

L17

ICPC

Foot/toe symptom/complaint

2.0

210.1

3564

20685

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

209.4

2130

9904

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.4

209.1

578

931

N06AX12

ATC

bupropion; oral

3.0

204.5

1304

4627

H03AA01

ATC

levothyroxine sodium; systemic

1.9

202.9

3561

20884

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

202.6

5375

36270

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

201.6

2407

12054

B01AA03

ATC

warfarin; systemic

2.3

201.3

2173

10383

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

200.5

1712

7251

WX290

NOMESCO Finland

Other blockade of nerve

1.7

200.2

6950

50804

K02.1

ICD-10 Finland

Caries of dentine

1.7

198.8

8532

66253

T83

ICPC

Overweight

6.4

198.7

551

891

A10BG03

ATC

pioglitazone; oral

6.8

198.1

527

805

L15

ICPC

Knee symptom/complaint

2.0

196.1

2921

16050

J01FA06

ATC

roxithromycin; oral

1.7

195.7

5937

41605

A10AE05

ATC

insulin detemir; parenteral

3.5

195.4

1010

3076

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

5.0

194.6

663

1374

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

193.5

3870

23715

XCK10

NOMESCO Finland

Photography of fundus of eye

2.7

192.0

1481

5910

R02

ICPC

Shortness of breath/dyspnoea

2.4

191.5

1773

7830

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.6

190.8

1500

6053

M10.9

ICD-10 Finland

Gout, unspecified

3.7

190.2

890

2499

R03BA02

ATC

budesonide; inhalant

2.0

189.9

2753

14940

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

188.9

1326

4995

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

188.9

1475

5925

A10BB01

ATC

glibenclamide; oral

5.5

188.4

593

1123

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.8

187.3

1345

5138

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.7

186.0

568

1037

C09AA05

ATC

ramipril; oral

2.0

185.9

2784

15290

N06AB10

ATC

escitalopram; oral

1.9

184.9

3345

19725

J45

ICD-10 Finland

Asthma

2.5

184.5

1636

7053

C09CA01

ATC

losartan; oral

2.0

184.0

2960

16709

N05BA04

ATC

oxazepam; oral

1.9

183.8

3645

22193

J01MA12

ATC

levofloxacin; systemic

2.1

183.6

2517

13326

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

183.6

2273

11520

N03AX12

ATC

gabapentin; oral

2.1

182.1

2304

11786

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

179.4

1181

4265

C08CA13

ATC

lercanidipine; oral

2.4

178.1

1666

7376

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

178.0

1524

6439

N05CF01

ATC

zopiclone; oral

1.8

174.3

4245

27560

C09BA02

ATC

enalapril and diuretics; systemic

3.0

173.1

1120

3993

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.9

173.0

1145

4145

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.6

173.0

642

1453

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

172.5

1555

6747

R06.5

ICD-10 Finland

Mouth breathing

2.6

172.3

1392

5688

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

171.6

1659

7462

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

171.5

2975

17205

M25.5

ICD-10 Finland

Pain in joint

1.7

169.7

4224

27562

E66.1

ICD-10 Finland

Drug-induced obesity

116.5

169.5

184

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

169.0

2834

16174

M01AE02

ATC

naproxen; oral, rectal

1.6

169.0

8250

64934

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

168.4

1116

4041

M01AB05

ATC

diclofenac; systemic, rectal

1.6

167.9

9481

77491

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

167.7

2164

11126

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.8

167.7

773

2138

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

166.7

989

3323

R03BA05

ATC

fluticasone; inhalant

1.9

165.6

2742

15559

L03

ICPC

Low back symptom/complaint

1.8

164.4

3467

21411

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

163.5

3705

23413

A10BD07

ATC

metformin and sitagliptin; systemic

3.9

161.8

712

1891

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.5

161.6

507

955

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

160.5

2444

13418

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

160.2

3887

25067

A08AA10

ATC

sibutramine; oral

33.1

159.7

212

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

159.6

5746

41491

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

159.6

4353

29078

R03BB04

ATC

tiotropium bromide; inhalant

2.6

158.4

1269

5149

C02AC05

ATC

moxonidine; oral

3.9

158.0

690

1820

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

157.0

7966

62747

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.7

156.2

743

2108

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

155.6

1568

7180

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

155.6

6684

50426

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

155.4

3733

23955

R03AC03

ATC

terbutaline; inhalant

2.0

155.4

2197

11699

R03DC03

ATC

montelukast; oral

1.9

154.8

2512

14109

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

154.3

1611

7502

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.6

154.1

566

1266

R05FB02

ATC

cough suppressants and expectorants

1.6

154.1

5050

35445

N06AB06

ATC

sertraline; oral

2.2

153.7

1827

9033

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

11.0

153.0

301

279

M01AH05

ATC

etoricoxib; oral

1.6

152.1

8317

66501

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

151.7

2461

13804

M03BX02

ATC

tizanidine; oral

1.6

151.3

9023

73673

358

Kela drug reimbursment

liraglutide

22.1

151.0

224

103

A10BH05

ATC

linagliptin; oral

4.0

150.8

648

1684

J46

ICD-10 Finland

Status asthmaticus

4.5

149.6

567

1309

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

148.2

7307

56783

WX723

NOMESCO Finland

CPAP therapy

3.8

147.6

661

1781

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

147.3

2476

14055

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.3

146.3

406

656

C10AA05

ATC

atorvastatin; oral

1.7

145.7

4094

27420

B81

ICPC

Anaemia vit B12/folate deficiency

4.1

145.6

602

1510

A28

ICPC

Limited function/disability NOS

2.2

145.3

1582

7503

A08

ICPC

Swelling

3.8

145.3

665

1825

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

144.3

2043

10854

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

144.3

10025

84482

C09DA01

ATC

losartan and diuretics; oral

2.4

143.7

1348

5943

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.6

143.3

441

811

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

142.8

5013

35639

N06AX11

ATC

mirtazapine; oral

1.7

142.7

4401

30219

EBA00

NOMESCO Finland

Extraction of tooth

1.6

142.3

4555

31589

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

141.6

7008

54259

R06AE07

ATC

cetirizine; oral

1.6

141.1

6353

48058

J01MA02

ATC

ciprofloxacin; systemic

1.6

139.4

4968

35405

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.2

139.3

806

2651

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

139.2

2012

10766

S76

ICPC

Skin infection other

3.2

139.0

796

2599

J96.1

ICD-10 Finland

Chronic respiratory failure

7.0

138.7

356

516

P01AB01

ATC

metronidazole; oral, rectal

1.6

138.7

5712

42207

P76

ICPC

Depressive disorder

2.6

138.3

1134

4646

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

136.4

1764

9013

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

135.7

823

2798

C09CA06

ATC

candesartan; oral

1.8

134.2

2851

17471

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

134.0

734

2321

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

133.7

1031

4079

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

133.0

5609

41555

R01AD09

ATC

mometasone; nasal

1.5

132.6

6561

50486

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

132.4

2193

12335

A10BJ05

ATC

dulaglutide; parenteral

11.6

132.2

253

222

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.8

131.7

595

1613

SPAT1254

SPAT

Administration of medicine

2.0

130.8

1865

9905

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

6.8

130.5

342

511

A02BC01

ATC

omeprazole; systemic

1.7

129.3

3581

23728

H02AB07

ATC

prednisone; oral

2.0

129.1

1988

10872

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

128.7

2988

18792

ACC51

NOMESCO Finland

Release of median nerve

2.4

128.1

1159

5001

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

128.0

8266

67380

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

127.7

1819

9648

A10BX01

ATC

guar gum; systemic

3.9

127.0

550

1437

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

127.0

2726

16718

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

126.9

2475

14716

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.0

126.3

539

1390

N05AX12

ATC

aripiprazole; systemic

3.1

126.1

734

2423

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

125.7

1191

5261

SPAT1310

SPAT

Counselling related to known health issue

1.6

123.7

4225

29551

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

123.6

1591

8087

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

123.4

4105

28512

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

123.4

3321

21778

P06

ICPC

Sleep disturbance

2.1

123.2

1483

7324

N02AA05

ATC

oxycodone; systemic

2.0

123.1

1664

8634

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

6.1

122.8

351

589

C07AB02

ATC

metoprolol; systemic

1.9

122.8

2223

12870

SPAT1263

SPAT

Sampling

1.5

122.5

5708

43028

M02AA07

ATC

piroxicam; topical

1.6

122.5

4608

33007

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

28.0

122.3

169

D01AC02

ATC

miconazole; topical

2.4

122.2

1097

4710

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

122.2

1306

6115

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

122.0

3192

20753

A06AD11

ATC

lactulose; oral

2.1

121.9

1626

8386

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

121.6

10104

86660

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

121.2

3017

19321

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

121.2

3323

21885

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

121.0

715

2384

SPAT1139

SPAT

Nutrition survey

3.7

120.8

568

1592

P03

ICPC

Feeling depressed

2.1

120.7

1515

7618

Z71.8

ICD-10 Finland

Other specified counselling

1.7

120.3

3401

22581

N05BA01

ATC

diazepam; systemic, rectal

2.0

119.9

1822

9891

N03AX09

ATC

lamotrigine; oral

2.7

119.9

879

3369

N05AA02

ATC

levomepromazine; systemic

3.2

119.5

683

2224

SPAT1229

SPAT

Assessment of need for aid

2.5

119.4

992

4084

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

8.8

119.3

265

307

H02AB04

ATC

methylprednisolone; systemic

1.9

118.5

2011

11366

N06AA09

ATC

amitriptyline; systemic

2.2

118.5

1371

6650

K04.0

ICD-10 Finland

Pulpitis

2.0

117.6

1599

8306

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

116.3

1556

8026

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

116.1

991

4139

A02BC03

ATC

lansoprazole; oral

1.6

116.0

3712

25436

N05CD07

ATC

temazepam; oral

2.1

115.8

1441

7213

J01FA09

ATC

clarithromycin; systemic

1.6

115.5

4502

32412

J01CE08

ATC

benzathine benzylpenicillin; parenteral

9.2

115.3

249

275

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

115.2

3556

24131

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

5.1

114.9

378

751

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

114.7

7441

60030

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

114.1

1059

4620

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

114.0

2839

18139

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

113.7

1607

8469

A12BA01

ATC

potassium chloride; oral

3.6

113.6

548

1568

AA40B

NOMESCO Finland

17.1

113.4

183

108

ZXA00

NOMESCO Finland

Right side

1.6

112.3

3262

21753

XX_20

NOMESCO Finland

Bioimpedance measurement

62.9

112.0

131

R03DA04

ATC

theophylline; systemic, rectal

3.1

111.5

672

2270

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

111.4

5365

40477

C09DA06

ATC

candesartan and diuretics; oral

2.5

111.0

964

4061

207

Kela drug reimbursment

Chronic arrhythmias

2.1

110.1

1337

6613

M48.0

ICD-10 Finland

Spinal stenosis

2.1

109.6

1333

6596

J20

ICD-10 Finland

Acute bronchitis

2.1

109.4

1362

6810

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

108.9

5365

40616

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

108.8

1542

8128

UJF32

NOMESCO Finland

Coloscopy

1.7

108.4

3048

20114

R03BA01

ATC

beclometasone; inhalant

1.9

107.9

1940

11156

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

107.9

3507

24046

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.1

107.8

359

723

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

106.6

1331

6655

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

106.6

861

3483

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.5

105.9

328

608

N62

ICD-10 Finland

Hypertrophy of breast

2.8

105.8

736

2726

R53

ICD-10 Finland

Malaise and fatigue

1.7

105.6

2649

16910

WX002

NOMESCO Finland

Sedation and analgesia

1.7

105.6

2445

15244

J01CA04

ATC

amoxicillin; systemic

1.6

104.6

11485

102663

M54

ICD-10 Finland

Dorsalgia

1.9

104.5

1633

8926

T07

ICPC

Weight gain

6.5

103.8

281

439

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

102.7

1634

8987

D11

ICPC

Diarrhoea

1.9

102.1

1653

9148

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.3

102.0

394

925

SPAT1240

SPAT

Therapeutic discussion

1.9

101.9

1676

9328

B01AB04

ATC

dalteparin; parenteral

2.8

101.7

696

2552

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

101.7

1701

9525

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

101.6

1072

4968

R51.80

ICD-10 Finland

Headache

1.8

101.5

2154

13059

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

101.5

3973

28434

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.1

101.3

288

480

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

101.2

2072

12420

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

101.1

869

3636

M10

ICD-10 Finland

Gout

3.4

100.9

521

1572

SPAT1301

SPAT

No procedures

1.5

100.9

3908

27886

S29

ICPC

Skin symptom/complaint other

1.8

99.8

2055

12331

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

99.6

490

1424

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

99.2

1026

4712

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.0

99.1

254

368

R96

ICPC

Asthma

2.1

99.1

1168

5692

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

98.9

1662

9315

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

98.8

1061

4957

D07AC01

ATC

betamethasone; topical

1.5

98.7

4339

31842

A02BC05

ATC

esomeprazole; systemic

1.5

98.5

5210

39796

RD112

NOMESCO Finland

22.7

98.3

144

F34.1

ICD-10 Finland

Dysthymia

2.9

98.2

630

2217

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

98.1

1342

6956

S10

ICPC

Boil/carbuncle

2.6

98.0

782

3140

C08CA02

ATC

felodipine; oral

2.3

98.0

984

4452

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

97.8

1512

8218

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

97.7

1947

11558

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

97.6

629

2217

F50.8

ICD-10 Finland

Other eating disorders

12.7

97.5

178

142

I50

ICD-10 Finland

Heart failure

4.6

97.3

353

779

N06AX03

ATC

mianserin; oral

2.7

97.1

708

2695

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

96.7

2271

14176

E0000UV

ATC

1.5

96.7

5280

40554

K07

ICPC

Swollen ankles/oedema

3.2

96.7

531

1678

C01DA14

ATC

isosorbide mononitrate; oral

2.0

96.3

1273

6508

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

95.4

951

4285

A10BG02

ATC

rosiglitazone; oral

6.7

94.9

252

384

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

94.7

2055

12519

40199

ICD-8 Finland

Essential benign hypertension

5.6

94.5

287

520

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

94.1

1256

6441

L16

ICPC

Ankle symptom/complaint

2.0

93.6

1340

7065

C09CA03

ATC

valsartan; oral

2.2

92.4

1011

4760

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

92.2

730

2916

N05AX08

ATC

risperidone; systemic

2.2

92.0

971

4494

H3600, E113

ICD-10 Finland

6.9

91.5

237

349

WZC30

NOMESCO Finland

Teaching

1.8

91.0

1669

9623

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.2

90.8

293

570

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

90.2

977

4577

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

79.1

90.2

102

A01

ICPC

Pain general/multiple sites

2.2

89.7

1005

4782

M01AX05

ATC

glucosamine; oral

1.7

89.6

2056

12721

M01AC06

ATC

meloxicam; systemic, rectal

1.5

89.3

4679

35467

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.9

89.3

593

2132

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

89.3

1165

5917

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

89.0

1786

10599

S80.0

ICD-10 Finland

Contusion of knee

2.2

89.0

971

4564

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

88.8

526

1753

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

88.8

1732

10185

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

88.5

1174

6001

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

88.5

3037

20936

ZXA05

NOMESCO Finland

Left side

1.6

88.2

2967

20349

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

87.3

1702

10002

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

87.2

1645

9562

SPAT1255

SPAT

Intravenous administration of medicine

2.3

87.1

864

3878

M01AX17

ATC

nimesulide; oral

1.6

86.9

2870

19582

M79.7

ICD-10 Finland

Fibromyalgia

2.8

86.7

584

2116

WZA90

NOMESCO Finland

Other doctors statement

1.6

86.5

3026

20938

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.7

86.4

403

1121

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

86.2

2358

15317

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

85.8

1126

5725

SPAT1283

SPAT

Restricted health certificate

1.6

85.8

2817

19185

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

85.7

1138

5814

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

85.6

1973

12205

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

85.0

891

4105

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

84.9

2208

14138

SPAT1211

SPAT

Application of soft bandage

2.0

84.8

1142

5870

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

84.6

3690

26834

H3601, E113

ICD-10 Finland

5.9

84.5

247

427

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

84.4

3594

25999

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

84.4

948

4512

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

84.3

1355

7447

K04.08

ICD-10 Finland

Other specified pulpit

2.1

83.6

1037

5152

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

83.5

2858

19645

J01MA14

ATC

moxifloxacin; systemic

2.0

83.3

1143

5914

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

82.8

557

2016

R05

ICPC

Cough

1.6

82.8

2846

19579

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.1

82.4

341

855

C01AA05

ATC

digoxin; systemic

2.5

82.4

682

2791

A10BD03

ATC

metformin and rosiglitazone; systemic

5.8

82.3

242

422

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

82.2

2622

17699

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

81.4

1861

11471

M01AB01

ATC

indometacin; systemic, rectal

2.3

81.4

836

3817

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.0

80.9

492

1669

C02EA02

ATC

3.2

80.6

450

1438

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

80.6

2862

19823

J01FA10

ATC

azithromycin; systemic

1.4

80.5

8206

69971

XA420

NOMESCO Finland

Extensive sleep examination

5.4

80.4

250

466

E000001

ATC

1.6

80.1

2743

18832

R06.2

ICD-10 Finland

Wheezing

2.6

80.0

620

2445

N06AX26

ATC

vortioxetine; oral

2.2

79.9

869

4072

J01CF05

ATC

flucloxacillin; systemic

2.8

79.9

543

1980

J45.8

ICD-10 Finland

Mixed asthma

3.1

79.6

462

1515

C07AG02

ATC

carvedilol; oral

2.6

79.5

636

2552

R03AC12

ATC

salmeterol; inhalant

2.7

79.4

587

2253

RD140

NOMESCO Finland

166.9

79.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

79.0

1558

9172

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

78.8

1072

5526

L90

ICPC

Osteoarthrosis of knee

2.4

78.4

700

2980

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

78.4

626

2507

WX402

NOMESCO Finland

General anaesthesia

1.6

78.1

2215

14488

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

78.0

1135

6004

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.3

77.2

192

267

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

77.2

565

2153

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.5

77.2

285

641

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

77.1

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

76.9

1355

7681

M10.0

ICD-10 Finland

Idiopathic gout

3.6

76.8

372

1067

A10BX09

ATC

[U] dapagliflozin; oral

7.2

76.7

193

273

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

76.4

1003

5095

JDF21

NOMESCO Finland

Laparoscopic gastric banding

752.4

76.3

R03AC13

ATC

formoterol; inhalant

2.4

76.2

679

2887

L60.0

ICD-10 Finland

Ingrowing nail

2.6

75.9

607

2433

JAH01

NOMESCO Finland

Laparoscopy

2.3

75.7

732

3242

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.8

75.7

1547

9199

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

75.6

5769

46546

R50.9

ICD-10 Finland

Fever, unspecified

1.7

75.3

1697

10397

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

8.9

75.3

165

188

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

75.3

867

4167

WX320

NOMESCO Finland

Spinalanesthesy

1.5

75.2

2695

18663

A03

ICPC

Fever

1.6

74.9

2202

14523

SPAT1260

SPAT

Consultation of another employee

1.6

74.5

2152

14126

R74

ICPC

Upper respiratory infection acute

1.4

74.2

4064

30801

A10BH02

ATC

vildagliptin; oral

4.5

74.0

276

627

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.4

73.4

230

433

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

73.1

1306

7430

B01AF02

ATC

apixaban; oral

2.1

73.0

876

4282

L14

ICPC

Leg/thigh symptom/complaint

2.1

73.0

885

4347

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

72.8

365

1076

D07XC01

ATC

betamethasone, combinations; topical

1.8

72.8

1434

8422

SPAT1216

SPAT

Assessment of functional ability

1.7

72.7

1545

9292

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.2

72.6

287

690

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

72.6

472

1674

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.4

71.7

635

2691

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

71.6

1505

9020

H01

ICPC

Ear pain/earache

1.8

71.5

1431

8447

F32

ICD-10 Finland

Depressive episode

2.2

71.4

807

3844

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

70.9

1745

10954

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

70.8

1283

7328

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

70.4

424

1428

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

70.3

1750

11015

J01DA06

ATC

[U] cefuroxime; systemic

1.6

70.2

1920

12404

N05CF02

ATC

zolpidem; oral

1.6

70.0

2315

15693

R42

ICD-10 Finland

Dizziness and giddiness

1.6

70.0

2407

16473

G44.2

ICD-10 Finland

Tension-type headache

1.7

70.0

1807

11492

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

69.7

447

1568

N06AX05

ATC

trazodone; oral

3.1

69.6

412

1370

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.8

69.3

1339

7813

F50.3

ICD-10 Finland

Atypical bulimia nervosa

7.5

69.2

168

226

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

68.9

2146

14332

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.5

68.7

570

2332

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

68.7

1146

6360

C09DA03

ATC

valsartan and diuretics; oral

2.5

68.7

554

2233

W84

ICPC

Pregnancy high risk

2.6

68.5

541

2152

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.8

68.4

1334

7801

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

68.3

331

950

A04

ICPC

Weakness/tiredness general

1.7

68.3

1545

9460

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

68.2

2165

14521

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

67.8

1264

7285

M01AH02

ATC

rofecoxib; oral

1.7

67.7

1462

8823

R11

ICD-10 Finland

Nausea and vomiting

1.9

67.6

997

5292

R01AD08

ATC

fluticasone; nasal

1.4

67.5

3845

29250

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

67.1

1503

9170

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

67.1

634

2775

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

67.0

548

2223

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.7

66.7

309

855

3051

Kela drug reimbursment

17.9

66.5

105

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

66.4

893

4572

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.3

66.1

350

1076

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.2

66.0

705

3273

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

65.8

358

1123

W85

ICPC

Gestational diabetes

2.4

65.8

584

2475

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.8

65.6

289

767

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

65.6

318

914

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.7

65.6

468

1757

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

65.4

1045

5707

M79.1

ICD-10 Finland

Myalgia

1.6

64.9

1676

10643

D07AC13

ATC

mometasone; topical

1.4

64.8

3616

27355

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

64.8

3060

22402

RD250

NOMESCO Finland

+∞

64.6

K08.3

ICD-10 Finland

Retained dental root

2.1

64.0

812

4058

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.4

63.8

328

987

N03AX11

ATC

topiramate; oral

2.8

63.6

440

1620

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.6

63.4

300

845

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.5

62.9

530

2187

L08

ICPC

Shoulder symptom/complaint

1.5

62.5

2157

14734

WX892

NOMESCO Finland

Monitored bed care

2.0

62.5

837

4277

ZX120

NOMESCO Finland

Intravenous

1.8

62.4

1124

6395

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

62.4

1399

8526

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

62.4

884

4615

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

62.3

3508

26546

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

62.3

989

5387

N05AF03

ATC

chlorprothixene; systemic

2.8

62.2

415

1495

P99

ICPC

Psychological disorders other

2.7

62.2

443

1660

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

61.4

955

5164

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.9

61.4

210

437

SPAT1104

SPAT

Monitoring of emergency patient

2.0

61.0

785

3946

C10AA07

ATC

rosuvastatin; oral

1.5

60.8

2434

17175

M09AX01

ATC

hyaluronic acid; parenteral

2.5

60.6

521

2171

N05BA12

ATC

alprazolam; oral

1.7

60.6

1287

7716

J02AC01

ATC

fluconazole; systemic

1.3

60.3

5712

47174

N03AG01

ATC

valproic acid; systemic, rectal

2.0

60.2

811

4150

N05AB03

ATC

perphenazine; systemic, rectal

2.5

60.2

502

2057

N05AN01

ATC

lithium; oral

2.8

60.2

397

1420

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

60.2

823

4237

ZXA10

NOMESCO Finland

Bilateral

1.5

60.0

2068

14107

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

59.6

1078

6138

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

59.5

1117

6442

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

59.5

457

1791

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.3

59.4

561

2454

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

59.0

8846

78212

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

58.9

769

3884

E000003

ATC

2.2

58.9

637

2970

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

58.8

609

2783

R52.0

ICD-10 Finland

Acute pain

2.6

58.8

460

1821

Z01.7

ICD-10 Finland

Laboratory examination

1.7

58.7

1349

8277

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

58.5

665

3172

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

58.5

607

2777

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

58.5

1397

8666

N30.0

ICD-10 Finland

Acute cystitis

1.6

58.4

1662

10809

M02AA10

ATC

ketoprofen; topical

1.6

58.4

1842

12296

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.7

58.3

1242

7448

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

58.1

857

4542

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

58.1

341

1130

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

57.9

527

2262

AN1

Coronary angiography

1.8

57.9

999

5601

SPAT1312

SPAT

General health counselling

1.4

57.8

3956

30920

P29

ICPC

Psychological sympt/compl other

2.0

57.8

815

4245

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

57.7

847

4480

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

57.5

4002

31365

S21

ICPC

Skin texture symptom/complaint

1.7

57.3

1386

8625

N06AB05

ATC

paroxetine; oral

1.9

57.3

844

4470

K85

ICPC

Elevated blood pressure

1.7

57.2

1451

9149

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

57.1

650

3102

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

57.1

520

2234

WX110

SPAT

2.1

56.8

662

3191

B01AF01

ATC

rivaroxaban; oral

1.8

56.7

1104

6436

UJD02

NOMESCO Finland

Gastroscopy

2.3

56.7

577

2618

I50.1

ICD-10 Finland

Left ventricular failure

2.7

56.6

406

1528

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

56.6

326

1066

RD160

NOMESCO Finland

17.9

56.5

A02BA02

ATC

ranitidine; systemic

1.5

56.4

2136

14865

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.5

56.3

471

1934

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

56.1

1567

10138

N06AA12

ATC

doxepin; systemic

2.2

55.9

619

2915

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.8

55.7

193

408

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.4

55.7

302

6762

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.3

55.6

538

2382

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.7

55.4

399

1507

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

3.1

55.3

322

1062

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

55.1

582

2685

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

55.1

390

1458

D01AC03

ATC

econazole; topical

2.0

55.1

725

3675

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

5.7

55.1

163

288

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

55.0

1127

6672

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

55.0

555

2506

SPAT1234

SPAT

Support of social functional capacity

2.3

55.0

534

2369

L13

ICPC

Hip symptom/complaint

1.6

54.9

1606

10504

AA1AD

NOMESCO Finland

CT of head and brain

1.5

54.9

2398

17198

P01

ICPC

Feeling anxious/nervous/tense

1.6

54.8

1455

9284

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

54.5

742

3812

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

54.5

4786

38875

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

54.5

4087

32369

EBA30

NOMESCO Finland

Excision of root of tooth

2.2

53.8

607

2885

RK320

NOMESCO Finland

5.8

53.8

156

269

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

53.8

3867

30397

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.6

53.7

404

1564

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.1

53.7

305

988

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

53.7

1709

11412

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

53.7

714

3635

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

53.4

1052

6152

L30.4

ICD-10 Finland

Erythema intertrigo

4.4

53.4

202

467

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

53.4

12714

119947

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.4

53.4

494

2138

D10

ICPC

Vomiting

1.9

53.3

824

4439

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.6

53.3

1483

9575

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.7

53.3

390

1487

K78

ICPC

Atrial fibrillation/flutter

2.1

53.2

621

2992

C08DB01

ATC

diltiazem; oral

2.4

53.2

467

1968

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.5

53.0

437

1779

R52.9

ICD-10 Finland

Pain, unspecified

1.8

52.9

1001

5778

R03BB01

ATC

ipratropium bromide; inhalant

2.7

52.5

385

1470

T45

ICPC

Metabolic, Observ/health educat/advice/diet

3.9

52.4

225

585

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.4

52.3

270

816

R4120

NOMESCO Finland

Occupational therapy

1.9

52.2

761

4010

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

51.8

361

1336

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

51.8

268

812

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.4

51.7

264

791

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

51.7

870

4827

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

51.7

722

3744

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.2

51.5

205

498

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

51.4

642

3183

C09CA07

ATC

telmisartan; oral

1.9

51.2

753

3980

OAB72

SPAT

9.6

51.0

106

111

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

34.9

50.9

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5000

29628

1.99

323.01

2.1

1.7

mg/l

1.0

0.33

3896

22291

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

254

144

17.90

314.12

1.0

1.1

ug/l

70.8

87.4

4.74

226

113

(3007853) Bacteria identified in Skin by Aerobe culture

3204

14768

2.45

307.65

2.1

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3611

16908

2.45

307.65

2.8

2.4

g/l

2.5

2.4

28.61

3368

15712

(3016244) Insulin [Units/volume] in Serum or Plasma

726

589

12.85

307.65

4.7

2.7

mu/l

39.1

17.0

25.42

704

549

(3026493) Urate [Moles/volume] in Serum or Plasma

6339

32049

2.59

307.65

2.8

2.4

umol/l

3183.5

3554.4

0.35

5620

28252

(3042936) Bacteria identified in Isolate by Culture

3359

16829

2.25

307.65

2.5

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6554

41066

1.99

307.65

2.9

3.4

mmol/l

2.3

2.4

16.62

5846

36384

(3012516) Albumin [Mass/volume] in Urine

6703

31037

2.95

307.65

3.6

3.2

mg/l

205.0

477.7

8.27

4699

19199

(3033658) Prothrombin time (PT) actual/Normal

5559

32186

2.10

307.65

4.4

3.7

93.9

93.6

0.38

5399

31314

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14808

120147

3.28

307.65

8.9

4.7

mmol/mol

42.2

38.5

282.40

14242

112578

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9775

65043

2.23

307.65

5.8

6.0

umol/l

10.6

10.8

0.94

9339

61586

(3014576) Chloride [Moles/volume] in Serum or Plasma

3285

13390

2.81

307.65

7.5

7.3

mmol/l

104.5

104.6

0.75

3247

13127

(3021960) Folate [Moles/volume] in Serum or Plasma

5361

25455

2.64

307.65

1.9

1.5

nmol/l

21.6

20.5

6.89

4918

22088

(3023368) Bacteria identified in Blood by Culture

5328

29662

2.18

307.65

4.9

4.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12984

99796

2.42

307.65

8.3

7.2

u/l

81.2

75.4

46.00

12480

94191

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8961

47426

2.95

307.65

2.7

1.8

pmol/l

93.9

97.7

12.67

5490

24696

(3032080) INR in Blood by Coagulation assay

7030

45651

1.94

307.65

9.4

7.3

inr

1.2

0.19

1789

13887

(3018418) pH of Serum or Plasma

5966

34998

2.10

307.65

4.5

3.9

7.4

0.13

849

6690

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4383

13771

3.97

307.65

5.1

6.0

mmol/l

1.1

1.0

19.07

4202

12891

(3022948) Iron [Moles/volume] in Serum or Plasma

3880

18523

2.43

307.65

2.9

2.4

umol/l

12.7

13.9

21.62

3653

17250

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9364

53940

2.70

307.65

3.4

2.2

nmol/l

70.1

1731.5

0.50

8820

49552

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3369

15476

2.48

307.65

2.9

2.5

20.9

23.8

29.05

3004

13290

(1002224) Polysomnography panel

1712

6025

3.05

307.65

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2642

11821

2.47

307.65

2.1

2.2

nmol/l

336.3

377.9

21.21

2363

10937

(3009508) Creatinine [Moles/volume] in Urine

7197

35049

2.87

307.65

3.5

3.1

mmol/l

8.0

7.7

6.60

6155

29905

(3020682) Albumin/Creatinine [Ratio] in Urine

6995

32581

2.99

307.65

4.3

3.9

mg/mmol

11.1

9.2

1.83

4872

20366

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6033

29912

2.60

307.65

2.8

2.1

mg/l

3.2

2.8

27.00

5384

25651

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4839

18273

3.33

307.65

3.0

3.5

mmol/l

0.8

3.20

4616

17113

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

6690

43657

1.90

307.65

3.6

3.1

—

0.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9426

58978

2.40

307.65

7.9

6.3

mmol/l

1.2

14.01

8375

49925

(3019309) Folate [Moles/volume] in Red Blood Cells

4582

19154

2.93

307.65

2.2

1.7

nmol/l

1208.1

1169.2

2.16

3881

14629

(3024561) Albumin [Mass/volume] in Serum or Plasma

9658

51274

3.13

307.65

5.5

4.7

g/l

35.6

36.1

18.70

9222

47688

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9508

63230

2.19

307.65

4.1

2.8

ug/l

103.2

104.8

0.11

9027

59518

(3044640) Blood type and Crossmatch panel - Blood

6449

41065

1.94

307.65

2.5

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2487

10650

2.57

307.65

2.4

2.3

g/l

0.2

2.30

2338

9969

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5490

27934

2.45

307.65

3.4

2.7

ng/l

1115.0

1116.0

0.01

4553

23616

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7489

44019

2.28

307.65

3.3

3.2

u/l

30.9

32.7

2.04

7165

41930

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8691

53087

2.35

307.65

7.4

5.6

mmol/l

1.2

11.19

8145

48375

(3013826) Glucose [Moles/volume] in Serum or Plasma

10661

72746

2.32

307.65

6.2

4.3

mmol/l

7.1

6.5

88.41

10109

67136

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4432

24747

2.08

307.65

2.1

1.6

pmol/l

12529354.5

37299302.0

3.74

3887

21006

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13195

108430

2.09

301.25

5.1

4.0

pmol/l

14.5

14.6

0.31

12428

100383

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2152

9498

2.46

289.24

4.7

4.0

kpa

6.0

5.8

10.83

2092

9222

(3012544) pH of Venous blood

2180

9832

2.40

278.65

4.7

3.9

7.4

0.52

(3002032) Base excess in Venous blood by calculation

2121

9458

2.43

278.02

4.7

4.0

mmol/l

2.1

1.9

1.56

1790

7689

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2511

12068

2.27

276.86

8.7

7.3

kpa

5.3

5.1

32.60

2409

11562

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6064

39794

1.83

276.84

2.8

2.5

u/l

49.0

58.3

22.74

5658

36851

(3027801) Oxygen [Partial pressure] in Arterial blood

2510

12062

2.27

276.82

8.7

7.3

kpa

11.2

13.1

66.82

2402

11551

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14671

127129

2.40

270.51

6.4

4.6

mu/l

2.2

2.1

0.16

13951

118616

(3003396) Base excess in Arterial blood by calculation

2492

12065

2.26

269.39

8.7

7.3

mmol/l

1.3

0.9

4.72

2044

9394

(40768797) Stomach Pathology biopsy report

3256

17540

2.07

267.47

1.2

—

(3026008) Bacteria identified in Urine by Culture

5597

36147

1.83

266.95

3.4

2.7

—

(3000991) Gas panel - Venous blood

2018

8960

2.43

266.40

10.0

8.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1560

6140

2.70

264.86

4.0

3.2

kpa

5.3

5.1

18.09

1461

5677

(3009343) pH of Capillary blood

1543

6053

2.71

263.64

4.0

3.2

7.4

0.18

139

806

(3024354) Oxygen [Partial pressure] in Venous blood

1791

7711

2.48

252.18

3.9

3.3

kpa

4.8

4.6

2.82

1734

7460

(3006315) Basophils [#/volume] in Blood

8946

66930

1.74

251.18

6.5

5.8

e9/l

0.0

2.50

7707

58554

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1480

5835

2.69

249.90

4.0

3.2

mmol/l

2.0

1.6

3.04

1126

4231

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8549

63237

1.73

249.34

4.4

3.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2055

9457

2.34

249.19

8.6

7.2

mmol/l

1.4

1.3

2.27

1971

9155

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4913

31030

1.83

248.26

2.4

2.2

—

(3001604) Monocytes [#/volume] in Blood

8903

66697

1.73

247.08

6.5

5.8

e9/l

0.6

22.46

7693

58391

(3019198) Lymphocytes [#/volume] in Blood

9129

69024

1.72

243.47

6.6

5.8

e9/l

2.0

1.9

8.62

8035

61574

(3030467) Casts [#/volume] in Urine by Automated count

5206

33677

1.80

241.64

3.3

2.9

e6/l

0.5

0.4

3.20

3900

24970

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14780

129795

2.34

241.38

6.3

3.9

mmol/l

6.3

5.8

307.65

14014

120511

(3018095) Leukocytes [#/volume] in Urine

6455

44502

1.74

239.62

4.0

3.4

e6/l

82.6

89.8

0.35

4504

30434

(3013650) Neutrophils [#/volume] in Blood by Automated count

9941

77142

1.73

239.26

9.2

8.9

e9/l

4.6

4.0

131.84

8605

67785

(3013115) Eosinophils [#/volume] in Blood

9132

69358

1.71

236.66

6.9

6.0

e9/l

0.2

17.80

8040

61645

(3022313) Gas panel - Capillary blood

1189

4301

2.90

236.15

4.0

3.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

15347

137351

2.70

235.08

23.0

12.8

mmol/l

139.7

5.39

15156

133907

(3002582) Erythrocytes [#/volume] in Urine

5536

36786

1.76

232.30

3.4

3.0

e6/l

51.9

74.1

1.11

4208

27855

(3023103) Potassium [Moles/volume] in Serum or Plasma

15366

137799

2.69

230.70

23.2

12.9

mmol/l

4.0

3.9

8.94

15165

134066

(3016502) Oxygen saturation in Arterial blood

2176

10706

2.19

223.07

9.1

7.8

94.7

96.0

16.25

2113

10299

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2718

14563

2.04

222.47

2.6

2.7

umol/l

7.6

7.7

0.10

2281

12521

(3022217) INR in Platelet poor plasma by Coagulation assay

2568

13506

2.07

221.05

25.7

19.6

inr

1.3

1.2

1.73

268

2063

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1810

8295

2.33

220.10

4.4

3.8

ng/l

101.8

85.7

8.28

1632

7261

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

742

2170

3.53

210.02

2.2

nmol/l

1.0

0.8

11.42

598

1852

(40758558) Short blood count panel - Blood

5029

33380

1.73

206.49

6.8

—

(36304419) Bacteria [Presence] in Urine

5012

33260

1.73

205.82

3.2

2.8

—

(3044889) 12 lead EKG panel

11093

90494

1.69

204.32

4.0

3.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1924

9354

2.20

201.98

8.7

7.5

mmol/l

10.6

8.7

22.68

1844

8976

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3498

21033

1.84

200.50

2.8

2.9

mmol/l

2.4

0.33

3018

18427

(3031040) Bacteria [#/volume] in Urine by Automated count

10755

87418

1.66

196.81

5.3

4.0

e6/l

1571.5

1711.4

0.08

117

1023

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3400

20466

1.83

193.28

2.8

2.6

e6/l

1.4

1.2

0.33

1861

11412

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4976

33433

1.70

192.59

1.7

1.6

mmol/l

1.6

1.4

66.16

4381

28639

(3037467) Urinalysis macro (dipstick) panel - Urine

11197

92231

1.67

191.73

4.9

4.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1308

5503

2.50

191.44

10.7

9.8

mmol/l

24.7

24.2

6.47

1210

5189

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6201

44227

1.64

190.01

4.1

3.0

ng/l

55.9

56.0

0.00

3870

25708

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3047

17851

1.87

188.37

1.9

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11509

95663

1.67

188.29

4.0

2.9

u/l

52.4

42.0

27.84

10914

90568

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

437

941

4.74

187.65

1.6

1.3

nmol/l

1.7

1.4

4.92

409

838

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1017

3819

2.77

187.29

4.4

3.4

mmol/l

25.0

24.8

2.04

962

3531

(42870588) Differential panel, method unspecified - Blood

6135

43856

1.64

184.91

6.1

6.0

—

(3019060) Gas panel - Arterial blood

1485

6718

2.33

184.63

5.0

4.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1475

6734

2.31

179.31

10.6

9.4

93.0

94.2

9.21

1469

6713

(3026782) Osmolality of Urine

3680

23206

1.75

176.60

2.9

2.6

mosm/kgh2o

568.9

538.0

11.54

3112

19778

(3011397) Hemoglobin [Presence] in Urine by Test strip

4549

30490

1.68

174.20

4.2

3.4

—

(3019069) Monocytes/100 leukocytes in Blood

8136

62851

1.58

173.57

6.9

6.2

7.9

8.4

36.98

7683

59198

(3006504) Eosinophils/100 leukocytes in Blood

8100

62510

1.58

173.54

6.7

5.9

2.8

1.17

7608

58493

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2219

12006

1.98

173.12

2.5

u/l

63.6

39.5

0.53

1845

10379

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

736

2417

3.14

172.39

2.3

2.4

ug/min

116.5

99.2

0.41

447

1498

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1946

10067

2.06

172.11

9.9

8.1

g/l

124.5

121.6

7.14

1907

9687

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1455

6725

2.28

171.50

10.6

9.3

1.5

1.4

1.45

1444

6685

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1450

6698

2.28

171.13

10.7

9.4

0.6

0.7

3.52

1439

6659

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3140

19075

1.80

170.56

2.9

2.7

e6/l

5.4

3.1

12.50

1617

10083

(3018010) Neutrophils/100 leukocytes in Blood

8231

64130

1.57

166.39

6.6

5.8

58.8

56.6

65.20

7778

60369

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2205

12083

1.95

165.21

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2192

11990

1.96

165.11

1.8

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

8315

65040

1.56

164.39

6.8

6.0

27.2

28.9

45.70

7822

60989

(3022096) Basophils/100 leukocytes in Blood

7838

60522

1.56

163.95

6.7

6.0

0.6

0.7

19.78

7346

56675

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1169

5065

2.41

159.57

5.2

4.3

mmol/l

24.3

24.1

1.08

1054

4566

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14409

129362

1.90

159.35

4.9

3.5

mmol/l

1.6

1.2

303.09

13618

120930

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2960

18054

1.78

157.15

1.9

1.7

1.4

1.38

2616

16097

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1644

8257

2.10

156.63

2.9

2.7

ng/l

142.3

165.9

2.19

1417

7457

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1097

4663

2.45

156.11

3.6

3.0

0.7

0.16

1055

4462

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1052

4388

2.49

155.96

4.6

3.7

51.5

49.1

2.22

1039

4344

(3000850) Epithelial cells [#/volume] in Urine

3852

25338

1.68

155.41

2.7

2.4

e6/l

7.6

6.1

8.26

3336

22114

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1113

4785

2.42

154.44

3.6

3.0

1.4

1.3

3.05

1107

4755

(3021589) Normoblasts [#/volume] in Blood

7647

59319

1.54

152.58

10.4

8.7

e9/l

0.0

2.01

6107

48729

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15082

137981

2.09

151.12

20.1

11.9

mg/l

22.2

21.7

1.24

13691

106358

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14980

136745

2.04

150.52

6.0

4.3

mmol/l

2.7

2.9

146.32

14285

128032

(3004119) Hemoglobin [Mass/volume] in Venous blood

1322

6187

2.24

150.48

4.2

3.4

g/l

130.1

129.9

0.09

1292

6051

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1241

5719

2.27

146.50

2.2

1.6

mg/l

5.0

3.2

4.31

1145

3791

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14208

127788

1.81

145.19

17.1

10.7

ml/min/173m2

87.6

86.1

11.98

12258

105144

(3013707) Erythrocyte sedimentation rate by Westergren method

11685

100023

1.58

144.63

4.6

3.8

mm/h

15.9

10.5

249.40

10964

93606

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14729

134109

1.92

142.60

5.4

3.9

mmol/l

1.3

1.5

307.65

14006

125945

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14796

134949

1.94

142.07

5.4

3.9

mmol/l

4.4

4.8

307.65

14145

127131

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5017

35995

1.57

138.82

2.2

2.1

u/l

186.7

193.0

0.20

4741

33945

(3020891) Body temperature

975

4189

2.41

135.06

5.5

4.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2725

16892

1.73

134.48

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1705

9148

1.96

134.17

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

8334

66987

1.49

133.19

4.3

3.4

estimate

0.0

0.91

1332

12460

(3035350) Ketones [Presence] in Urine by Test strip

8248

66163

1.49

133.09

4.3

3.3

estimate

0.0

1.54

1364

12366

(3027273) Bicarbonate [Moles/volume] in Venous blood

1055

4750

2.30

131.22

3.9

3.4

mmol/l

25.4

25.2

0.63

1030

4605

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3376

22288

1.65

131.04

3.9

3.3

ng/l

259.9

466.4

2.08

2380

15330

(3021601) Nitrite [Presence] in Urine by Test strip

8251

66392

1.49

129.77

5.8

4.5

estimate

0.0

0.13

1431

12719

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1562

8329

1.97

124.70

1.7

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2004

11736

1.81

119.20

2.3

2.5

2.0

1.7

14.52

1763

10493

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1217

6117

2.07

114.28

1.8

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

587

2139

2.81

113.69

2.7

2.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1301

6808

1.99

109.06

1.7

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

761

3229

2.42

107.96

3.4

u/ml

0.3

0.03

417

1820

(3028717) Thiamine [Mass/volume] in Blood

117

110

10.70

107.94

1.3

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

185

304

6.14

107.10

2.0

1.2

umol/l

17.5

16.8

0.99

176

263

(3018405) Lactate [Moles/volume] in Arterial blood

826

3681

2.31

104.77

4.5

4.1

mmol/l

1.4

0.23

808

3624

(40761535) Cells panel - Urine sediment

1685

9718

1.82

104.62

4.0

3.3

—

(3013512) EKG study

4470

32915

1.49

102.92

4.4

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3919

28088

1.52

102.84

1.4

g/l

2.6

2.3

13.96

2310

17891

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4439

32653

1.49

102.68

1.3

u/ml

1.6

1.7

0.27

1126

9381

(4146454)

329

917

3.64

99.77

2.8

—

(3000494) Fungus identified in Specimen by Culture

2346

15088

1.65

97.85

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

241

555

4.39

95.13

2.1

1.6

nmol/l

1.6

1.1

7.10

184

443

(3037522) Nuclear Ab [Titer] in Serum

2909

19915

1.56

92.89

1.4

titre

524.7

547.9

0.24

516

4077

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2662

17902

1.58

91.79

2.2

2.1

30.2

29.5

5.68

2597

17344

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1222

6629

1.91

91.58

8.5

6.9

mmol/l

25.0

24.5

4.71

1151

6158

(4010399)

1529

8917

1.79

90.82

1.5

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1210

6735

1.86

83.47

8.6

7.1

mmol/l

25.3

24.7

5.88

1200

6687

(3019150) Specific gravity of Urine by Refractometry

3841

28434

1.46

82.72

4.9

3.6

kg/l

1.0

3.34

428

4191

(3020630) Protein [Mass/volume] in Serum or Plasma

1460

8635

1.76

82.26

1.8

2.5

g/l

66.5

66.8

0.92

1346

7927

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15455

146509

1.88

82.19

13.4

9.3

u/l

30.1

25.9

79.53

15153

142052

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

661

2968

2.28

82.12

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

698

3211

2.23

81.79

4.9

4.3

mmol/l

3.9

3.8

1.05

670

3038

(3034770) Mitochondria Ab [Titer] in Serum

767

3680

2.14

80.84

1.2

1.3

titre

1065.5

910.8

0.11

130

(3052851) Hemolysis interference index of Serum or Plasma

763

3657

2.14

80.63

3.2

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

798

3898

2.10

80.25

2.3

2.0

ug/l

1.9

2.1

0.35

714

3455

(44816559) Phosphatidylethanol [Mass/volume] in Blood

594

2574

2.36

80.15

1.3

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

574

2454

2.39

79.85

3.3

2.8

mmol/l

25.2

24.5

2.78

517

2139

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1937

12514

1.62

77.98

3.6

4.3

u/l

231.1

238.3

1.53

1832

11878

(3020717) Zinc [Moles/volume] in Serum or Plasma

244

664

3.71

76.70

1.9

1.4

umol/l

14.8

27.7

13.92

237

635

(3023520) Reticulocytes [#/volume] in Blood

1424

8568

1.72

75.20

2.5

2.6

e9/l

79.7

69.7

15.22

1040

6398

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

487

1986

2.50

75.12

1.1

iu/ml

41.7

5850.3

0.66

118

474

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1455

8857

1.70

73.57

2.4

2.2

ug/l

5.3

7.5

4.59

1232

7812

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2174

14681

1.55

72.00

8.8

6.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

511

2200

2.36

69.94

3.0

2.8

kpa

8.3

8.4

1.19

481

2039

(3017143) Hepatitis C virus Ab [Presence] in Serum

2559

18025

1.50

69.33

1.8

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

848

4464

1.95

69.07

1.4

1.3

u/l

8.9

11.2

7.00

693

3674

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

528

2320

2.32

68.95

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

527

2320

2.31

68.52

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

741

3734

2.03

68.36

1.2

1.3

titre

115.6

132.5

0.22

351

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3274

24250

1.44

68.27

1.3

u/ml

10.1

11.4

0.50

1270

10091

(3024928) Oxygen saturation in Venous blood

510

2235

2.32

67.01

4.3

3.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

874

4723

1.90

65.74

1.7

g/l

1.7

1.5

10.69

753

4070

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3412

25611

1.42

65.72

1.3

iu/ml

27.7

33.0

1.11

898

8108

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

468

2013

2.36

64.18

1.7

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3965

30661

1.39

63.85

1.8

1.6

—

(3037121) Protein [Mass/volume] in Urine

755

3924

1.97

63.76

2.9

3.1

g/l

0.3

0.48

380

1676

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1500

9537

1.63

63.71

3.0

3.4

pmol/l

4.5

1.59

1329

8601

(3019225) pH of Specimen

1700

11169

1.58

62.95

4.9

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1257

7660

1.69

62.92

1.6

1.9

g/l

1.1

1.3

5.66

1159

7069

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1592

10366

1.59

61.15

3.1

2.4

ml/min/173m2

70.2

70.8

0.18

710

3865

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

258

842

3.10

60.93

1.4

1.3

umol/l

5.4

5.1

0.73

238

778

(3028707) Methadone [Presence] in Urine by Screen method

575

2762

2.12

60.28

2.2

2.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

706

3682

1.96

58.98

2.4

2.3

ug/l

442.1

517.7

0.43

662

3412

(3013005) Retinol [Moles/volume] in Serum or Plasma

199

564

3.56

58.97

1.8

1.7

umol/l

1.8

2.0

1.70

189

521

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

465

2069

2.28

58.95

1.9

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1289

8068

1.65

58.06

2.7

2.1

nmol/l

8.8

12.3

45.20

1145

7199

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1004

5876

1.75

58.03

13.3

9.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1064

6330

1.73

58.02

1.7

1.6

mu/l

297.2

311.0

0.77

935

5690

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

201

580

3.50

57.97

1.7

1.6

nmol/l

3.5

17.4

0.78

159

479

(3004588) Protein electrophoresis panel - Serum or Plasma

1148

7007

1.69

56.94

1.7

2.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

655

3374

1.98

56.70

1.8

1.7

nmol/l

34.4

43.9

13.28

634

3295

(3009445) Proteinase 3 Ab [Units/volume] in Serum

904

5200

1.78

55.41

1.5

u/ml

11.0

13.6

0.33

151

(3029937) Albumin [Presence] in Urine by Test strip

4390

35121

1.34

55.36

5.0

3.7

estimate

0.0

0.74

1358

12397

(3005719) IgG [Mass/volume] in Serum or Plasma

1519

10007

1.57

55.21

2.4

2.7

g/l

10.6

10.5

0.30

1414

9194

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3434

26470

1.38

55.05

1.8

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

113

220

5.16

54.74

1.4

nmol/l

5.5

0.04

107

209

(3021901) Oxygen saturation in Capillary blood

402

1737

2.35

54.57

3.0

2.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

628

3263

1.96

53.00

1.3

1.5

iu/ml

15.8

15.1

0.03

(3023183) Ammonium ion [Moles/volume] in Plasma

479

2257

2.16

52.76

3.9

2.8

umol/l

36.3

34.0

1.09

411

1939

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

339

1387

2.47

51.96

7.3

6.5

mg/l

11.1

11.4

0.44

313

1289

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

905

5314

1.74

51.59

1.5

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

718

3948

1.86

51.00

1.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

718

3951

1.85

50.87

1.6

2.2

g/l

7.8

7.2

11.52

539

3011

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

717

3946

1.85

50.78

1.6

2.2

g/l

4.2

3.8

8.37

524

2861

(40761511) CBC panel - Blood by Automated count

15189

145403

1.57

50.77

18.5

11.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1236

7906

1.61

50.77

2.7

2.2

u/l

4859.8

5917.1

0.78

461

3172

(3011985) Renin [Units/volume] in Plasma

382

1703

2.27

48.23

1.5

1.6

mu/l

81.5

57.9

1.26

346

1540

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6106

51831

1.28

48.09

4.7

3.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

646

3516

1.87

47.36

1.4

ug/g

283.6

281.9

0.07

363

1977

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

465

2269

2.08

46.76

2.0

1.8

pmol/l

148.7

190.6

12.22

424

2170

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

576

3047

1.92

46.08

1.7

2.2

g/l

0.0

2.71

530

2790

(3035637) Corticotropin [Mass/volume] in Plasma

357

1577

2.29

46.08

1.7

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

709

4012

1.80

45.83

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1687

11803

1.48

45.79

4.0

3.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

621

3378

1.87

45.61

1.7

2.3

g/l

0.5

0.8

2.49

553

2945

(3000475) Leukocytes [#/volume] in Synovial fluid

536

2779

1.96

45.51

1.7

1.6

e6/l

15881.2

11847.8

0.87

360

2047

(3014765) Yersinia sp identified in Stool by Organism specific culture

713

4051

1.79

45.46

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

616

3347

1.87

45.40

1.9

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

661

3674

1.83

45.32

1.5

2.2

g/l

9.9

10.2

1.22

580

3114

(42529406) Shigella sp [Presence] in Stool by Culture

713

4058

1.79

45.20

1.2

—

(3025941) Bacteria identified in Stool by Culture

1245

8232

1.55

44.14

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

428

2070

2.10

44.08

3.8

2.8

mmol/l

1.6

1.5

0.77

420

2019

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

694

3952

1.79

43.91

2.5

2.7

g/l

4.0

3.6

12.67

657

3734

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

667

3754

1.81

43.88

1.6

2.3

g/l

3.2

3.0

2.95

534

2951

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

269

1070

2.54

43.83

2.2

2.0

nmol/l

19.0

19.1

0.09

256

1013

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

723

4170

1.77

43.79

1.5

1.6

titre

178.8

318.4

0.70

176

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

570

3067

1.89

43.30

1.6

2.1

g/l

36.9

38.4

6.86

504

2673

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

531

2792

1.93

43.26

1.6

2.2

g/l

0.0

0.92

485

2545

(3000492) Spirometry study

1891

13675

1.43

42.96

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

524

2751

1.93

42.88

1.6

2.2

g/l

0.0

0.00

483

2541

(1616796) Gas panel - Central venous blood

470

2381

2.00

42.65

3.9

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

326

1436

2.30

42.39

2.9

3.0

nmol/l

0.8

0.20

259

1062

(3012898) Urea [Moles/volume] in Urine

104

6.56

42.36

1.7

1.5

mmol/l

200.4

165.0

1.37

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

234

893

2.64

41.52

13.3

11.6

mmol/l

0.6

0.00

213

828

(3036489) Thrombin time

828

5033

1.68

41.45

2.0

2.1

20.7

21.2

2.41

723

4308

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

687

3986

1.75

40.74

2.3

2.5

186.1

179.4

1.24

654

3763

(3011288) Drugs identified in Urine by Screen method

747

4440

1.71

40.64

2.1

2.9

—

(3048689) Calprotectin [Mass/mass] in Stool

2426

18510

1.36

39.90

2.3

2.4

ug/g

140.9

117.5

3.16

1967

14509

(40768441) Liver Pathology biopsy report

240

951

2.55

39.46

1.4

—

(3044941) Cell count panel - Synovial fluid

370

1776

2.11

38.90

1.5

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

12538

117385

1.28

38.77

23.4

14.4

14.1

13.6

154.53

12366

115071

(3006184) Hemoglobin [Mass/volume] in Capillary blood

464

2424

1.94

38.55

2.3

2.1

g/l

132.2

130.7

0.56

301

1740

(46235355) HIV 1 and 2 tests - Meaningful Use set

3881

31803

1.29

38.33

2.0

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

544

3004

1.84

38.08

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

166

556

3.01

37.65

1.9

2.1

umol/l

134.2

138.1

0.04

278

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

337

1582

2.15

37.54

1.3

1.4

pmol/l

294.0

330.1

0.75

281

1204

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

713

4280

1.70

37.39

2.1

2.3

95.1

93.1

1.46

661

3958

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1936

14439

1.39

36.41

5.4

3.9

30.5

32.5

15.10

1569

10191

(3038515) Glucose [Moles/volume] in Venous blood

388

1944

2.02

36.35

4.1

2.9

mmol/l

7.6

7.5

0.46

382

1902

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

779

4827

1.64

36.16

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

149

482

3.11

35.90

1.9

2.1

ug/min

226.8

93.7

0.38

104

(3009466) Valproate [Moles/volume] in Serum or Plasma

368

1821

2.04

35.69

6.0

5.1

umol/l

354.5

372.9

1.44

330

1581

(3003694) ABO and Rh group [Type] in Blood

4850

41138

1.25

35.41

1.6

1.5

—

(4034850)

699

4240

1.68

35.23

11.4

8.3

—

(36660697) Celiac disease serology panel - Serum

1600

11618

1.42

35.12

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

532

2997

1.80

34.89

1.8

3.4

mg/l

54.8

69.3

0.34

438

2428

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

531

2995

1.80

34.69

1.8

3.4

mg/l

37.7

43.8

0.57

435

2436

(3021788) Differential panel - Synovial fluid

407

2114

1.95

34.42

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

381

1941

1.99

34.08

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

518

2918

1.80

33.98

1.8

3.4

ratio

3.2

2.4

0.16

259

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

892

5801

1.57

33.84

1.1

u/ml

1.9

9.3

0.88

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

725

4498

1.64

33.47

2.2

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

697

4293

1.65

33.11

6.2

4.9

1.8

1.7

0.47

663

4009

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

699

4314

1.65

32.95

1.6

1.8

g/l

0.3

0.2

17.81

658

4114

(1001926) Buprenorphine [Presence] in Urine by Screen method

795

5081

1.59

32.49

2.0

2.1

—

(21494755) Public health laboratory ask at order entry panel

1307

18032

0.70

32.07

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

712

4449

1.63

31.94

1.6

1.8

g/l

1.3

1.2

42.69

676

4256

(3033705) Calcium.ionized [Moles/volume] in Venous blood

248

1102

2.27

31.70

2.7

2.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

244

1078

2.28

31.62

1.2

titre

179.7

202.9

0.15

205

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

241

1077

2.26

30.41

1.2

titre

90.0

84.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1145

8036

1.46

30.10

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

512

2980

1.74

30.04

1.5

1.3

u/l

15.3

29.3

32.96

428

2425

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

856

5664

1.54

30.02

2.1

2.0

u/l

38.4

39.4

0.78

755

5139

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1566

11629

1.38

29.91

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

677

4247

1.62

29.88

6.3

4.9

0.8

0.9

5.79

648

3969

(3005322) IgE [Units/volume] in Serum or Plasma

1320

9559

1.41

29.21

1.4

1.3

u/ml

239.4

223.3

0.17

1235

8859

(3017569) Oxygen content in Arterial blood

127

424

3.01

29.08

2.2

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1510

11220

1.38

28.68

1.2

iu/ml

129.9

153.2

1.50

530

4443

(1761482) Bacteria [#/volume] in Urine by Culture

447

2538

1.78

28.60

4.6

3.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

255

1196

2.15

28.58

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

608

3756

1.64

28.55

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

741

4809

1.57

28.33

2.1

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

409

2273

1.82

28.11

1.3

1.2

u/ml

5.0

4.0

0.60

167

993

(3000330) Specific gravity of Urine by Test strip

852

5715

1.52

28.03

3.7

3.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1305

9500

1.41

27.99

4.1

3.5

mmol/l

1.2

5.47

1143

8322

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

417

2341

1.80

27.72

1.3

1.2

u/ml

3.6

3.4

0.06

117

805

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

317

1636

1.96

27.40

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

412

2317

1.80

27.24

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

537

3263

1.67

26.91

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3778

31962

1.24

26.68

4.7

4.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

263

1282

2.07

26.68

1.1

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

679

4387

1.57

26.47

2.0

1.8

—

(3016879) Cocaine [Presence] in Urine

894

6134

1.48

26.34

2.0

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

340

1823

1.88

26.22

1.2

1.3

nmol/l

0.6

1.8

0.82

325

1761

(3016650) Hepatitis A virus Ab [Presence] in Serum

401

2263

1.79

26.22

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

357

1949

1.85

26.02

1.2

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

394

2218

1.80

25.98

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

190

823

2.32

25.88

1.4

2.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

306

1592

1.94

25.85

1.2

u/l

39.8

34.1

0.20

270

1394

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10867

101686

1.20

25.85

3.8

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

954

6656

1.46

25.80

1.9

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

339

1826

1.87

25.78

1.2

1.3

nmol/l

0.1

0.2

1.37

109

(3022145) Colonoscopy Study observation

1870

14634

1.31

24.98

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

887

6145

1.47

24.87

2.4

2.3

—

(3010421) pH of Blood

485

2930

1.68

24.87

5.0

3.4

7.4

1.97

404

2444

(3030981) Hyaline casts [#/volume] in Urine by Automated count

881

6106

1.47

24.65

2.8

2.5

e6/l

0.5

0.2

2.43

847

5903

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

222

1049

2.13

24.49

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

953

6715

1.44

24.45

1.9

2.0

—

(3027008) Opiates [Presence] in Urine

951

6700

1.44

24.42

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1344

10051

1.37

24.39

1.3

iu/l

21.2

28.9

20.67

1093

8771

(3002256) Pathology report gross observation

2190

17574

1.28

24.12

1.2

1.3

—

(4306422)

392

2282

1.74

23.07

1.2

—

(3027944) Amphetamines [Presence] in Urine

931

6609

1.43

22.93

1.9

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

562

3595

1.58

22.90

2.2

2.1

mg/l

11.8

10.7

2.48

515

3374

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

148

4.13

22.78

13.6

9.7

mmol/l

5.5

5.4

0.09

148

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

387

2259

1.73

22.56

1.1

—

(3006270) Folate [Moles/volume] in Blood

212

1017

2.10

22.52

1.2

1.1

nmol/l

402.7

380.9

0.79

169

917

(40757494) Bilirubin.total [Moles/volume] in Blood

148

615

2.42

22.21

2.1

2.3

umol/l

17.0

29.5

0.71

(3020876) Protein [Mass/time] in 24 hour Urine

186

857

2.18

21.93

1.6

2.0

g/24h

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

159

688

2.32

21.79

1.4

1.5

u/ml

20.1

22.4

0.20

146

(40760888) Immunoglobulin light chains.free panel - Serum

385

2281

1.70

21.29

1.7

3.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

184

855

2.16

21.25

12.3

12.1

nmol/l

782.2

827.8

0.63

176

826

(3027315) Oxygen [Partial pressure] in Blood

415

2512

1.67

21.18

5.1

3.5

kpa

8.8

0.01

406

2463

(3012501) Base excess in Blood by calculation

412

2490

1.67

21.15

5.0

3.5

mmol/l

3.1

2.3

5.23

295

1642

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.41

21.12

2.2

1.4

umol/24h

355.0

315.6

0.55

(3013290) Carbon dioxide [Partial pressure] in Blood

412

2491

1.67

21.12

5.0

3.5

kpa

5.2

5.0

9.27

403

2443

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

291

1593

1.84

21.11

1.1

96.1

95.4

0.14

275

1499

(3051611) Lipemic interference index of Serum or Plasma

238

1221

1.96

21.04

3.5

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

784

5490

1.45

20.78

1.9

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

189

896

2.12

20.75

18.7

17.1

nmol/l

1435.2

2492.3

0.49

179

859

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

368

2173

1.71

20.62

1.1

126.3

118.3

4.31

332

1977

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

209

1034

2.03

20.49

1.1

mg/l

300.1

291.7

0.84

181

942

(3017732) Neutrophils [#/volume] in Blood

1266

9631

1.34

20.45

2.9

2.6

e9/l

4.5

4.0

10.58

1027

7844

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2367

19527

1.25

20.37

2.1

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

608

4065

1.51

20.33

1.4

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

313

1778

1.78

20.12

1.1

g/l

1.5

0.00

279

1621

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

252

1340

1.89

20.05

1.2

u/l

59.6

59.8

0.02

183

887

(40767503) Oxygen content in Capillary blood by calculation

376

2255

1.68

19.90

3.0

2.3

16.5

16.6

0.15

221

1098

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

250

1339

1.88

19.47

1.4

mmol/l

11.6

0.01

134

244

(3036603) Volume of Urine

169

788

2.16

19.40

1.5

1.6

1842.1

2008.5

0.32

160

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2601

21798

1.23

19.25

2.2

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

207

1046

1.99

19.16

3.9

2.8

mg/l

62.2

63.8

0.03

152

747

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

294

1676

1.77

18.70

2.5

u/ml

717.2

962.6

0.11

283

1569

(3040151) Glucose [Moles/volume] in Capillary blood

226

1191

1.91

18.52

13.7

10.1

mmol/l

8.5

7.1

1.36

178

990

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

158

731

2.17

18.52

1.2

u/l

19.0

21.0

0.33

141

621

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

161

751

2.15

18.49

1.2

u/l

80.5

86.5

0.51

149

653

(3037756) Immunofixation for Serum or Plasma

336

2000

1.69

18.33

1.3

1.8

—

(40768804) Tissue Pathology biopsy report

6264

56913

1.16

18.30

2.1

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

553

3711

1.51

18.20

1.2

1.1

—

(3011648) Oxygen content in Venous blood

180

884

2.05

18.07

2.5

2.4

12.0

11.0

2.40

180

884

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

322

1908

1.70

17.87

1.5

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

371

2286

1.64

17.73

1.2

titre

176.0

181.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

135

599

2.26

17.55

1.1

1.3

titre

74.3

61.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

1049

1.94

17.33

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1041

7920

1.34

16.76

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

366

2283

1.62

16.68

1.5

1.6

g/l

0.7

0.23

299

1732

(3022689) Creatine [Moles/volume] in Urine

324

2.69

16.50

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

424

2.46

16.40

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

707

5075

1.41

16.38

1.6

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

672

4786

1.42

16.28

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

273

1591

1.73

16.15

1.5

1.6

iu/ml

28.3

33.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

127

570

2.24

16.11

1.2

1.1

iu/ml

3.3

3.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

200

1062

1.89

16.09

1.5

24.5

33.7

3.46

134

647

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

273

2.83

16.04

1.2

pmol/l

295.9

316.2

0.18

212

(3026692) Albumin [Mass/volume] in Peritoneal fluid

247

2.92

15.92

1.6

1.4

g/l

14.1

13.0

0.47

183

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

319

2.67

15.90

1.6

1.2

nmol/l

68.6

123.2

6.40

244

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

320

2.66

15.80

2.4

1.8

e6/l

5690.3

15732.5

0.73

158

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

185

965

1.93

15.72

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1246

15666

0.78

15.53

1.8

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

375

5730

0.65

15.37

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

375

5728

0.65

15.34

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

372

5691

0.65

15.33

1.4

—

(3051651) Icteric interference index of Serum or Plasma

151

740

2.05

15.33

3.7

3.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

272

1613

1.70

15.13

1.2

1.3

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

110

479

2.31

15.02

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

364

2.51

14.98

2.5

2.0

e6/l

484.9

3084.8

0.61

242

(40768443) Skin Pathology biopsy report

758

5592

1.37

14.93

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

377

5713

0.65

14.86

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

214

3.00

14.84

1.3

1.4

g/l

29.7

25.5

1.07

160

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.40

14.68

1.6

1.8

umol/l

41.5

45.7

0.43

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

976

1.88

14.58

1.4

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

976

1.88

14.58

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

976

1.88

14.58

1.4

1.8

—

(3004775) Volume in Urine collected for unspecified duration

156

790

1.98

14.49

2.4

2.3

701.5

645.7

0.64

105

568

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

399

2627

1.53

14.45

1.5

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

178

949

1.89

14.21

3.1

2.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

413

6085

0.67

14.17

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

407

2703

1.52

14.16

1.5

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

702

5171

1.37

13.97

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

155

794

1.96

13.95

1.2

—

(3014271) Vancomycin [Susceptibility]

402

2.37

13.88

3.3

2.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

193

1066

1.82

13.79

1.4

e6/l

75713.3

92257.3

0.18

145

730

(3045414) Leukocytes [Presence] in Urine

799

6022

1.34

13.72

1.9

1.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

104

3.85

13.72

1.5

1.2

mg/24h

447.0

349.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

155

800

1.95

13.66

1.3

1.5

ug/l

6.4

7.7

0.90

138

723

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

151

775

1.96

13.53

1.0

1.1

nmol/l

3.2

7.6

0.83

151

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

413

2782

1.50

13.45

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

1268

10198

1.26

13.38

4.5

4.2

0.1

0.32

356

2572

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

202

1142

1.78

13.37

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1321

10682

1.26

13.30

4.6

4.1

1.0

0.9

0.24

377

2772

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

240

1427

1.69

13.29

1.5

1.6

59.8

53.4

1.56

153

893

(4062490)

244

1460

1.68

13.19

1.6

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

794

6027

1.33

13.01

1.3

u/ml

0.7

1.1

0.74

518

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1601

13265

1.23

12.91

2.1

1.9

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

331

2.45

12.82

1.3

56.2

50.8

0.61

284

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

124

3.47

12.72

1.1

—

(3044927) Protein electrophoresis panel - Urine

173

948

1.83

12.72

1.3

1.1

—

(3003338) MCHC [Mass/volume]

12666

122332

1.15

12.69

25.9

15.0

g/l

329.4

332.7

283.59

12575

121470

(43055514) Macroprolactin [Presence] in Serum or Plasma

101

457

2.22

12.67

1.7

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

100

451

2.22

12.65

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

466

3255

1.44

12.64

3.1

3.3

mg/l

1.7

1.4

11.69

425

3029

(3001556) Androgen free Index in Serum or Plasma

145

3.25

12.52

1.5

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

310

4690

0.65

12.18

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

320

4805

0.66

12.12

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

151

808

1.88

12.00

2.2

2.0

99.8

97.5

0.38

143

735

(3027135) IgG subclass 1 [Mass/volume] in Serum

238

1453

1.65

11.96

1.5

1.3

g/l

6.4

6.7

0.72

185

1009

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

831

10642

0.77

11.90

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

457

2.17

11.86

2.5

1.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

237

1453

1.64

11.73

1.5

1.3

g/l

2.9

3.0

0.57

188

1007

(3024139) IgG subclass 3 [Mass/volume] in Serum

237

1453

1.64

11.73

1.5

1.4

g/l

0.4

0.39

187

1008

(3005033) Fetal Nuchal fold Thickness US

313

4683

0.66

11.66

1.4

—

(3020491) Glucose [Moles/volume] in Blood

171

963

1.78

11.54

2.2

1.7

mmol/l

7.3

6.3

2.61

108

709

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

401

5712

0.69

11.53

2.1

1.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

132

685

1.93

11.53

1.5

1.2

u/l

272.0

338.9

0.38

125

630

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

239

1479

1.62

11.41

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

103

491

2.10

11.38

3.1

2.7

—

(3033799) Differential panel - Peritoneal fluid

314

2.39

11.31

2.7

1.8

—

(3045716) Anion gap in Serum or Plasma

100

474

2.12

11.22

3.2

2.6

mmol/l

9.0

9.2

0.19

350

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

225

1379

1.64

11.17

2.7

1.9

mg/l

28.0

24.7

0.42

341

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

7.28

10.97

4.9

6.6

mmol/l

0.2

0.16

(3002179) Metamyelocytes/100 leukocytes in Blood

1196

9780

1.24

10.89

3.9

4.0

0.5

0.7

1.20

282

2026

(3025468) Yersinia sp identified in Specimen by Organism specific culture

248

1567

1.59

10.89

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

191

1131

1.70

10.83

1.5

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

418

2948

1.43

10.82

1.5

1.4

u/ml

12.0

20.9

—

(4268621)

254

1617

1.58

10.80

2.4

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

421

2975

1.43

10.78

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

248

1572

1.59

10.75

1.5

—

(4198724)

130

691

1.89

10.61

1.7

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

247

1571

1.58

10.56

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

460

2.09

10.51

2.0

2.3

ug/l

0.7

1.2

2.64

435

(21494890) Protein electrophoresis panel - 24 hour Urine

174

1014

1.72

10.48

1.4

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

390

2733

1.44

10.47

1.5

1.4

u/ml

106.6

112.5

0.58

612

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1255

10361

1.23

10.44

1.9

1.8

—

(37021550) Renin [Units/volume] in Plasma --upright

259

2.48

10.42

1.3

1.4

mu/l

85.4

52.5

0.66

200

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

176

1031

1.71

10.41

3.4

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

177

1039

1.71

10.39

1.1

—

(3019977) pH of Arterial blood

109

550

1.99

10.37

2.8

2.6

7.4

0.90

171

(3044007) Cell count panel - Peritoneal fluid

298

2.35

10.22

2.3

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

204

1249

1.64

10.22

1.5

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

127

680

1.87

10.15

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

250

1615

1.56

10.02

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

246

1584

1.56

10.00

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

223

2.56

9.98

2.0

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

246

1585

1.56

9.97

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

761

5986

1.28

9.66

1.4

1.3

miu/ml

190.9

231.0

2.55

327

2938

(3006922) Hepatitis E virus Ab [Presence] in Serum

168

995

1.70

9.58

1.1

—

(3025159) Blasts/100 leukocytes in Blood

1175

9724

1.22

9.56

4.7

4.2

0.0

0.3

1.90

302

2193

(3009542) Hematocrit [Volume Fraction] of Blood

13388

130434

1.14

9.50

21.5

12.7

40.1

40.0

0.75

10115

101745

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

668

1.85

9.44

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

387

2773

1.41

9.23

1.2

1.3

u/ml

276.1

269.8

0.17

243

1829

(3008116) Ketones [Moles/volume] in Urine by Test strip

238

2.44

9.22

1.3

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

222

1424

1.57

9.22

2.2

1.7

89.4

90.4

1.80

217

1405

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

820

6549

1.27

9.21

1.4

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

260

1728

1.51

9.19

2.2

1.7

mmol/l

1.8

1.7

1.35

253

1693

(43055442) Apixaban [Mass/volume] in Serum or Plasma

105

3.24

9.13

1.5

ug/l

99.8

115.8

0.43

(3004809) Band form neutrophils/100 leukocytes in Blood

270

1814

1.50

9.07

2.7

3.3

1.2

1.4

0.69

219

1419

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

286

1947

1.48

9.00

1.2

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

407

2955

1.39

8.99

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

163

979

1.67

8.86

3.0

3.9

—

(44806118)

205

1305

1.58

8.82

1.5

—

(44790049)

205

1305

1.58

8.82

1.5

—

(44790047)

205

1306

1.58

8.79

1.5

—

(44790048)

205

1306

1.58

8.79

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

222

1445

1.54

8.67

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

911

7423

1.24

8.60

1.1

titre

90.0

222.3

2.26

203

(3045424) Erythrocytes [Presence] in Urine

317

2224

1.43

8.55

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

262

2.29

8.35

1.3

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

122

2.95

8.31

1.0

1.2

mg/l

39.3

44.5

0.92

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

527

1.88

8.16

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

527

1.88

8.16

1.4

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

478

1.93

8.15

1.3

1.4

pmol/l

13.4

14.9

1.48

404

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

414

3065

1.36

8.15

1.2

1.3

mmol/l

3.9

3.7

3.26

387

2886

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

127

731

1.74

8.11

1.7

146.5

133.3

1.26

121

681

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

366

2666

1.38

7.98

1.6

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

122

2067

0.59

7.98

1.5

1.6

—

(3024263) Appearance of Synovial fluid

111

619

1.80

7.90

1.7

1.8

—

(3025315) Body weight

100

3.10

7.80

5.9

3.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

322

2.12

7.79

1.1

—

(40768793) Breast Pathology biopsy report

241

3491

0.69

7.74

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

249

1706

1.47

7.66

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

403

3002

1.35

7.65

1.2

1.3

u/ml

4.9

2.5

0.38

250

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

123

2.85

7.61

9.7

7.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

2007

1.43

7.58

1.5

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

366

2.03

7.57

6.2

5.8

mmol/l

25.2

24.9

0.19

345

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

205

2.39

7.54

1.1

u/ml

0.5

0.1

0.54

129

(3016750) Collection duration of Urine

105

585

1.80

7.52

2.2

min

511.6

498.8

0.73

463

(3014148) Varicella zoster virus Ab [Titer] in Serum

295

2100

1.41

7.40

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.53

7.40

1.0

u/ml

0.4

0.1

0.73

(3022621) pH of Urine by Test strip

1001

8372

1.21

7.36

3.3

2.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

489

1.87

7.33

8.7

4.9

mg/l

2062.0

2456.6

0.07

357

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

159

999

1.60

7.32

1.3

1.4

umol/l

12.6

11.4

1.23

145

955

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

580

4574

1.28

7.30

1.7

2.0

—

(3023410) Appearance of Cerebral spinal fluid

213

1429

1.50

7.30

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

466

3578

1.31

7.21

2.2

2.5

—

(3003181) Sodium [Moles/volume] in Urine

254

1771

1.44

7.16

1.2

1.4

mmol/l

64.3

63.9

0.05

193

1416

(3008898) HLA-B27 [Presence]

726

5892

1.24

7.16

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

144

891

1.62

7.07

1.5

1.4

mmol/l

5.8

5.5

2.49

134

846

(3023419) Bacteria identified in Sputum by Culture

197

1310

1.51

7.06

2.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

553

1.79

7.06

1.1

1.2

g/l

0.3

2.96

445

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.66

7.06

1.2

1.1

nmol/24h

84.8

97.6

0.35

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

147

917

1.61

6.99

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

131

795

1.65

6.95

1.6

u/l

5.0

0.01

374

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

146

911

1.61

6.94

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

280

2000

1.41

6.92

2.2

2.7

u/ml

153.5

2041.7

—

100

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

307

2231

1.38

6.86

1.4

1.3

mmol/l

7.4

6.9

2.13

231

1647

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

452

3484

1.31

6.82

1.3

mg/l

454.0

484.7

0.95

435

3332

(3051101) Glucose [Moles/volume] in Cord blood

160

2.50

6.81

6.0

5.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

107

620

1.73

6.75

1.6

mmol/24h

4.0

5.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

510

1.81

6.75

1.2

114.2

111.3

0.61

462

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

406

3088

1.32

6.75

1.4

e6/l

1199.0

2399.2

0.42

322

2534

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

405

3084

1.32

6.68

1.3

1.4

e6/l

44.4

22.7

0.31

305

2406

(4024509)

167

1089

1.54

6.59

1.8

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

526

4159

1.27

6.53

1.3

u/ml

26.6

34.1

0.24

286

(44806420)

232

2.20

6.53

2.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

348

2603

1.34

6.50

4.5

5.7

iu/ml

15486.7

1775.7

0.45

367

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

518

1.78

6.43

1.1

96.2

92.1

0.79

225

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

129

799

1.62

6.36

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

384

2924

1.32

6.36

1.2

u/ml

6.2

16.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

553

4420

1.26

6.29

1.6

iu/ml

3.0

6.2

0.29

118

910

(3039162) Centromere protein B Ab [Units/volume] in Serum

261

1875

1.40

6.29

1.3

u/ml

45.0

60.4

0.41

135

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.45

6.27

1.0

u/ml

0.2

0.1

0.41

(3037556) Urate [Mass/volume] in Serum or Plasma

310

2.00

6.24

1.2

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

484

3811

1.28

6.23

1.3

u/ml

6.7

8.0

0.23

640

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

173

2550

0.67

6.18

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

384

2937

1.31

6.17

2.1

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

375

1.90

6.11

1.5

1.6

ug/l

10.5

8.4

2.67

375

(3034274) Bile acid [Moles/volume] in Serum --fasting

334

2509

1.34

6.09

2.4

2.1

umol/l

6.2

6.5

0.14

235

1820

(3003888) Timothy IgE Ab [Units/volume] in Serum

385

2957

1.31

6.02

1.1

u/ml

3.3

5.4

3.53

219

1508

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

479

1.78

5.96

3.1

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

213

1495

1.43

5.88

1.3

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

318

1.95

5.83

1.9

1.7

—

(40768800) Prostate Pathology biopsy report

110

1758

0.62

5.80

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

296

2202

1.35

5.78

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

450

3550

1.28

5.74

2.3

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

472

3747

1.27

5.72

1.3

u/ml

7.3

6.0

0.12

416

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

413

3226

1.29

5.71

1.2

1.3

u/ml

27.1

41.0

1.07

334

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

510

1.73

5.63

1.1

100.7

93.2

1.20

228

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

200

1400

1.43

5.63

2.8

3.2

nmol/l

5.2

9.4

0.53

184

1359

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

1567

1.41

5.62

1.5

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

137

891

1.54

5.55

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

526

6479

0.81

5.54

1.5

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

152

2.37

5.53

2.4

2.8

pmol/l

74.1

60.3

0.17

129

(3007461) Platelets [#/volume] in Blood

15678

155309

1.19

5.50

30.1

17.6

e9/l

265.7

257.6

46.15

15432

151913

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

159

1070

1.49

5.49

1.9

1.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

135

2.45

5.43

4.8

2.6

mmol/l

1.6

1.2

0.33

100

(3012565) Volume of 24 hour Urine

562

1.68

5.39

2.1

2.2

1833.8

2028.9

1.10

513

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

193

2.18

5.32

6.8

6.4

64.6

71.4

0.71

151

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.68

5.15

1.5

1.2

ml/s/173m2

1.1

2.0

0.47

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

125

811

1.55

5.15

1.4

1.3

u/l

506.7

371.3

1.15

117

774

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

473

3816

1.25

5.04

1.8

2.0

iu/l

3.2

13.7

1.15

169

1531

(3010375) cycloSPORINE [Mass/volume] in Blood

573

1.64

5.03

27.2

27.7

ug/l

116.6

115.3

0.06

475

(3008401) Mugwort IgE Ab [Units/volume] in Serum

360

2812

1.29

5.03

1.1

u/ml

0.6

1.2

2.82

166

1153

(3020191) Ethanol [Moles/volume] in Serum or Plasma

158

1086

1.46

4.95

1.6

1.4

promille

1.1

1.3

1.33

123

818

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

176

1236

1.43

4.93

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

134

893

1.50

4.90

2.1

1.9

u/field

2.5

2.0

0.44

399

(4281824)

208

1506

1.39

4.89

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3989

37432

1.09

4.83

3.7

2.9

—

(3035941) MCH [Entitic mass]

15679

155429

1.18

4.83

29.9

17.5

29.7

30.2

257.91

15556

153679

(3023199) Leukocytes [#/volume] in Pleural fluid

153

1051

1.46

4.82

1.7

1.5

e6/l

4449.1

2729.3

0.30

110

760

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

106

675

1.57

4.77

1.4

1.6

—

(3024731) MCV [Entitic volume]

15680

155449

1.18

4.77

30.0

17.5

90.0

90.7

71.33

15557

153696

(3026361) Erythrocytes [#/volume] in Blood

15680

155465

1.17

4.68

30.1

17.5

e12/l

4.6

4.5

45.69

15405

151757

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.71

4.66

1.0

1.1

u/ml

0.0

0.8

1.00

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

1059

1.45

4.65

1.2

1.3

u/ml

0.9

1.1

0.11

446

(3026389) Candida sp identified in Specimen by Organism specific culture

274

2088

1.32

4.64

1.5

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

218

2.02

4.64

1.1

1.3

nmol/l

0.2

0.3

0.68

148

(3044290) Cell count panel - Cerebral spinal fluid

362

2864

1.27

4.60

1.3

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

128

2.35

4.55

1.1

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

186

2.10

4.55

1.2

1.6

nmol/l

590327.1

401289.0

0.17

156

(3010813) Leukocytes [#/volume] in Blood

15681

155503

1.17

4.52

30.2

17.6

e9/l

7.4

6.6

307.65

15401

151742

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

144

992

1.46

4.50

1.1

iu/ml

8.1

7.7

0.08

277

(3028308) Erythrocytes [#/volume] in Pleural fluid

139

951

1.47

4.50

1.7

1.4

e6/l

60830.9

44454.5

0.35

562

(3042517) Benzodiazepines panel - Urine

194

2.06

4.47

2.8

2.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

974

8494

1.16

4.46

2.5

3.1

u/ml

39.6

46.3

0.56

930

8200

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

500

1.64

4.44

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

500

1.64

4.44

1.4

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

15681

155520

1.17

4.42

30.3

17.6

g/l

134.3

135.5

19.74

15566

153768

(3047181) Lactate [Moles/volume] in Blood

441

3589

1.23

4.40

8.1

5.4

mmol/l

1.4

1.3

2.44

401

3156

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

322

1.80

4.38

3.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

322

1.80

4.38

3.6

2.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

183

2.08

4.34

2.8

2.2

—

(3042733) HLA Ab [Presence] in Serum

438

1.67

4.22

4.9

5.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.26

4.18

1.1

1.4

nmol/l

683.7

558.6

0.30

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

490

4055

1.21

4.17

2.9

3.6

u/ml

471.4

1822.3

1.16

409

3485

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.48

4.11

1.9

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1140

10113

1.14

4.09

2.2

2.3

au/ml

19.4

22.5

0.36

709

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

291

2278

1.28

4.08

1.6

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.75

4.08

1.5

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.70

4.07

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

710

1.51

4.07

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

128

881

1.46

4.07

2.7

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

181

2446

0.74

4.05

3.2

3.6

u/ml

27.5

32.9

0.27

175

2359

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

202

1.98

4.04

2.7

2.1

mmol/l

7.9

7.8

0.07

112

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

376

3038

1.24

4.04

1.5

1.4

nmol/l

0.4

0.15

308

2381

(3033923) Metanephrine [Moles/time] in 24 hour Urine

237

1.90

4.04

1.1

umol/24h

0.8

0.9

0.27

127

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.50

4.03

3.6

1.6

66.2

60.4

0.29

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

130

2.23

3.97

1.1

—

(4094501)

423

3472

1.22

3.93

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

644

1.52

3.92

1.8

1.7

u/field

2.1

2.5

0.25

466

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.64

3.91

1.8

2.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

184

2.01

3.91

1.2

1.3

—

87.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

136

955

1.43

3.90

1.1

ratio

1.1

0.11

347

(3004451) EKG impression Narrative

479

1.61

3.90

1.3

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

402

3292

1.23

3.83

1.1

u/ml

0.9

1.4

0.88

180

1272

(3025577) Chromium [Mass/volume] in Blood

552

1.56

3.83

1.9

2.1

ug/l

2.1

2.4

0.47

468

(3026470) Cobalt [Mass/volume] in Blood

568

1.55

3.82

1.9

2.0

ug/l

4.0

3.5

0.18

500

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1047

9283

1.14

3.81

1.2

1.3

au/ml

33.6

47.9

0.96

405

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

1212

1.37

3.81

2.3

3.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

272

1.80

3.76

1.4

1.6

ug/l

0.5

0.4

0.50

177

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

120

830

1.45

3.75

1.5

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

354

1.70

3.74

1.1

mg/g

6.5

6.4

0.05

331

(3003434) Protein [Mass/volume] in Pleural fluid

163

1191

1.37

3.73

1.7

1.4

g/l

34.4

33.7

0.30

149

1084

(40761536) Microorganisms panel - Urine sediment

1282

11532

1.12

3.69

4.3

3.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

217

1.89

3.66

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

543

1.55

3.64

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

297

1.75

3.64

1.3

38.8

41.6

0.18

205

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.67

3.63

2.4

2.2

mu/l

1.9

2.4

0.21

(3036670) Protein [Mass/volume] in Synovial fluid

305

1.74

3.62

1.3

1.2

g/l

36.5

39.2

0.70

160

(3006462) Nitrate [Presence] in Urine

617

1.51

3.59

3.2

2.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1174

1.37

3.59

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

374

1.66

3.57

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1175

1.37

3.57

1.2

—

(3002619) Bacteria identified in Specimen by Culture

255

1.81

3.56

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

722

0.55

3.55

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

925

1.41

3.51

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

161

1188

1.36

3.50

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

159

1173

1.36

3.46

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

118

829

1.43

3.43

1.4

u/l

7.2

5.8

0.52

709

(3034891) Synovial lining cells/100 cells in Synovial fluid

560

1.52

3.41

1.5

5.6

3.3

0.42

124

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1186

1.35

3.39

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1186

1.35

3.39

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

634

1.49

3.38

1.4

1.3

u/l

13.6

13.5

0.00

586

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.57

3.37

3.5

1.5

18.1

20.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

1034

1.38

3.36

1.3

—

(3034426) Prothrombin time (PT)

522

1.54

3.36

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

499

1.55

3.34

3.4

3.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

519

4417

1.18

3.33

1.4

—

(4211845)

670

1.47

3.30

3.1

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

894

1.40

3.30

1.2

—

(3008295) Osmolality of Serum or Plasma

154

1140

1.35

3.30

1.5

mosm/kgh2o

283.5

279.8

1.09

107

897

(3039000) Anion gap in Blood

305

2474

1.24

3.25

9.8

6.5

mmol/l

11.7

11.2

1.70

281

2216

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

142

1041

1.37

3.24

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

463

1.56

3.24

2.4

3.0

umol/l

29.4

27.9

0.41

359

(3036782) Glucose [Moles/volume] in Pleural fluid

124

889

1.40

3.24

1.4

1.3

mmol/l

6.8

6.2

1.04

112

821

(3018572) Chloride [Moles/volume] in Blood

305

2475

1.24

3.24

9.8

6.5

mmol/l

105.1

105.3

0.35

281

2217

(3045788) Cell count panel - Pleural fluid

116

823

1.41

3.22

1.7

1.5

—

(3016038) Potassium [Moles/volume] in Urine

675

1.45

3.19

1.1

1.2

mmol/l

32.1

34.9

0.65

590

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

452

3818

1.19

3.19

1.5

1.4

pmol/l

110.6

112.9

0.04

433

3723

(40768446) Kidney Pathology biopsy report

497

1.53

3.18

1.5

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

671

0.57

3.17

1.6

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2815

29906

0.93

3.15

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

104

2.21

3.14

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

477

4054

1.18

3.14

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

412

1.58

3.12

16.9

9.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

105

2.19

3.08

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2190

23472

0.92

3.08

3.7

3.9

21.7

0.08

784

10710

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

100

698

1.44

3.05

1.1

96.7

94.6

0.24

571

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

181

1.88

3.03

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1867

17295

1.09

3.02

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

126

919

1.37

3.00

1.7

1.5

—

(44813793)

145

1085

1.34

2.94

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

250

1.72

2.90

1.1

1.2

u/ml

0.0

3.0

—

(3047189) Immunofixation for 24 hour Urine

460

1.52

2.90

1.3

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

656

1.44

2.90

1.1

u/l

17.6

23.7

1.10

511

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

266

1.69

2.87

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

659

1.43

2.83

1.1

u/l

85.4

85.6

0.01

530

(3051387) C reactive protein [Mass/volume] in Capillary blood

310

2560

1.21

2.83

4.9

3.1

mg/l

24.8

25.1

0.05

181

1564

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

702

1.41

2.81

1.1

u/ml

4.5

10.1

2.49

119

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

161

1235

1.31

2.77

1.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

482

1.50

2.75

1.4

2.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

6.00

2.69

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

420

1.53

2.69

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1133

0.70

2.68

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

734

1.39

2.68

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

253

2062

1.23

2.65

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

148

1130

1.31

2.65

2.8

3.3

59.1

57.2

0.53

105

736

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

176

1.82

2.62

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

407

1.53

2.62

1.8

2.3

e6/l

147.3

225.0

0.69

214

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

273

2248

1.22

2.60

1.1

—

(3036180) Methadone [Presence] in Urine

3.60

2.57

1.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

474

1.48

2.56

1.5

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

474

1.48

2.56

1.5

2.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

128

1.95

2.54

2.0

1.9

—

(40762814) Titanium [Mass/volume] in Blood

143

1.89

2.49

2.0

2.3

ug/l

3.0

4.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

428

1.50

2.49

1.0

1.1

u/ml

1.3

3.9

0.59

235

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

652

1.40

2.48

1.5

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.32

2.47

1.1

1.3

ug/l

170.4

113.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

479

1.46

2.45

1.1

1.2

g/l

—

0.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

256

1.64

2.44

1.3

1.6

—

(4027681)

135

1032

1.31

2.43

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

343

1.55

2.41

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

580

1.42

2.41

1.2

—

(3018133) Calcium [Moles/volume] in Urine

204

1.72

2.39

1.5

1.8

mmol/l

2.9

2.7

0.23

182

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

610

1.40

2.32

1.4

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

610

1.40

2.32

1.4

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

610

1.40

2.32

1.4

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

610

1.40

2.32

1.4

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

503

4412

1.14

2.29

1.1

u/ml

3.4

6.0

1.49

657

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

579

1.40

2.27

2.6

2.4

umol/l

57.1

51.7

0.66

494

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

270

1.59

2.24

7.2

7.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

326

1.54

2.23

1.1

71.3

71.8

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

5.56

2.21

1.0

—

(3001729) Color of Synovial fluid

2.07

2.16

1.1

1.5

—

(4015189)

281

1.57

2.15

3.0

2.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

329

1.52

2.15

1.1

107.2

83.5

—

(3024932) HLA-DR beta [Type]

435

1.45

2.14

1.1

—

(3024471) HLA-A [Type]

445

1.44

2.11

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

189

1540

1.23

2.07

1.0

1.1

—

63.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

482

0.60

2.05

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

231

1.60

2.01

2.4

—

(3035880) pH of Pleural fluid

486

1.40

1.95

1.2

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

135

1068

1.27

1.94

1.2

u/ml

41.9

44.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

926

0.72

1.93

1.1

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

120

1.83

1.92

1.3

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1985

18772

1.07

1.90

1.8

1.7

—

(40768806) Pleura Pathology biopsy report

123

966

1.28

1.89

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

473

1.40

1.88

1.2

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

2.65

1.86

1.1

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

197

1.63

1.85

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

441

1.41

1.84

1.9

2.1

ug/l

62.1

59.4

0.15

429

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

132

1050

1.26

1.83

1.2

u/ml

82.2

43.8

—

(3015183) Erythrocyte sedimentation rate

893

0.73

1.83

1.3

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

u/ml

5.5

10.0

—

(3048879) Bone marrow aspiration report

286

1.50

1.80

1.2

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

165

1349

1.23

1.80

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

151

1228

1.23

1.74

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

122

970

1.26

1.72

1.8

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

1469

0.79

1.72

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.29

1.70

1.1

nmol/l

270.5

254.9

0.07

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1130

10529

1.08

1.69

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

195

1.59

1.67

1.4

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

159

1308

1.22

1.66

1.1

1.2

mg/l

40.2

39.5

0.10

139

1098

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.86

1.65

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

157

1.66

1.65

2.4

2.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

520

1.35

1.64

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.25

1.63

1.1

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

262

1.49

1.59

3.3

2.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

246

1.51

1.59

1.4

1.2

ug/l

19.5

191.4

2.67

134

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.95

1.58

1.6

1.2

mmol/l

22.7

21.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

175

1.60

1.57

1.0

u/ml

0.0

0.1

1.34

102

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

779

1.27

1.55

1.2

—

(3013466) aPTT in Blood by Coagulation assay

1.85

1.55

1.2

1.1

35.4

37.0

0.93

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.11

1.54

1.2

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

200

1696

1.18

1.53

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

588

1.31

1.52

1.6

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

225

1.51

1.50

1.1

1.2

titre

26.8

114.5

—

(3017509) Phencyclidine [Presence] in Urine

185

1.57

1.50

1.8

1.7

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

333

0.60

1.50

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

333

0.60

1.50

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

333

0.60

1.50

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

333

0.60

1.50

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

145

1197

1.21

1.49

1.2

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

687

1.28

1.48

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

591

1.30

1.48

35.3

ug/l

7.2

7.4

0.47

544

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

292

1.44

1.47

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

153

1274

1.20

1.45

1.1

mg/l

228.0

242.7

0.69

139

1116

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.37

1.45

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

228

0.53

1.44

1.0

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

102

1.77

1.44

1.3

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.12

1.44

5.7

9.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

317

2801

1.13

1.42

1.1

u/ml

2.4

2.0

0.19

691

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

969

1.23

1.42

2.2

2.7

e6/l

562.6

518.6

0.55

808

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.85

1.39

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

246

1.46

1.39

1.2

mg/l

53.1

64.6

0.07

186

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

263

1.45

1.38

1.4

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

1.37

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

150

1.60

1.37

1.1

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.61

1.36

1.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.61

1.36

1.3

umol/l

1884.1

3180.7

—

(3017704) Immunofixation for Urine

520

1.31

1.36

1.1

1.7

—

(1761868) Lipid panel - Serum or Plasma

5285

54125

0.97

1.36

3.1

2.5

—

(36303858) Crystals [Presence] in Urine

2.94

1.36

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

135

1.63

1.35

2.0

2.4

u/field

0.5

0.7

0.62

135

(3038071) Oxygen [Partial pressure] in Mixed venous blood

248

1.45

1.34

7.1

7.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

592

1.29

1.33

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

601

1.28

1.33

1.6

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

168

1.55

1.31

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.74

1.30

1.0

u/ml

0.1

0.5

1.22

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

209

1.48

1.29

1.2

1.5

ng/l

91.8

76.1

0.17

128

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.76

1.28

1.5

1.4

25.7

33.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

210

1821

1.16

1.27

2.4

2.5

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

0.7

2.6

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

1.9

1.7

0.13

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

2.2

1.8

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

1.2

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

1.4

2.5

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

2.8

4.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

1.0

2.1

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

0.5

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

122

1.64

1.27

1.5

1.6

mg/l

2.9

2.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

219

1.46

1.25

4.3

5.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

211

1.47

1.24

1.6

1.8

pmol/l

55.2

47.8

0.18

180

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

2.40

1.24

1.0

1.2

au/ml

—

739.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

126

1050

1.20

1.23

1.7

2.2

74.9

73.8

0.41

120

1005

(3004616) Nuclear Ab [Presence] in Serum

199

1724

1.16

1.23

1.4

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

114

942

1.21

1.22

2.3

2.8

e9/l

0.2

0.31

807

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

157

1337

1.18

1.21

1.9

2.1

31.5

32.9

3.35

157

1326

(40757373) Influenza virus identified in Isolate

229

1.44

1.21

1.7

1.6

—

(3028433) Virus identified in Specimen by Culture

434

1.31

1.21

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

557

1.28

1.21

2.6

3.1

mg/l

7.9

0.00

438

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

107

881

1.22

1.19

1.1

u/l

1.0

1.1

0.25

368

(3038177) Helicobacter pylori Ab [Presence] in Serum

294

2622

1.12

1.19

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.31

1.18

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.74

1.18

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

125

1.60

1.17

1.5

1.6

mg/l

0.4

2.5

3.77

(3026726) Creatinine [Moles/volume] in Specimen

1.70

1.17

2.9

2.5

umol/l

233.1

395.2

0.41

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1249

11849

1.06

1.16

3.2

4.1

ug/l

36.4

22.7

0.69

981

9286

(3017400) Magnesium [Moles/volume] in Urine

2.50

1.15

1.2

1.0

mmol/l

2.9

2.2

—

(3045142) Bone marrow Pathology biopsy report

1200

0.82

1.14

1.2

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

150

1.53

1.14

1.0

u/ml

0.0

1.0

0.76

106

(40768795) Lymph node Pathology biopsy report

107

1286

0.83

1.13

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.85

1.13

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

743

1.23

1.12

1.1

miu/ml

1664.0

1487.0

0.67

743

(3047007) Chlamydophila sp Ab [Presence] in Serum

257

2286

1.13

1.10

1.2

—

(4212803)

1.67

1.09

1.1

—

(3011412) CD3 cells [#/volume] in Blood

154

1323

1.17

1.09

2.1

2.5

e9/l

1.3

1.2

0.96

775

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.82

1.08

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

407

1.30

1.08

1.4

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

128

1.56

1.08

2.1

3.1

mg/l

1.6

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.19

1.08

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

122

1031

1.18

1.06

1.6

2.2

13.9

13.7

0.07

493

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

168

1459

1.15

1.05

3.4

4.7

u/ml

72.3

101.4

0.44

456

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

372

0.70

1.04

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

1.03

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.27

1.03

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

555

0.76

1.03

2.8

3.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1631

17001

0.95

1.03

2.6

2.8

ug/l

0.6

0.7

2.81

1074

10640

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

173

1509

1.15

1.02

1.2

—

(3000285) Sodium [Moles/volume] in Blood

130

1.54

1.02

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

164

1426

1.15

1.01

1.0

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.89

1.01

1.3

1.6

u/l

0.0

0.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.17

0.98

1.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

223

1.39

0.98

1.0

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.97

0.0

2.4

—

26.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

173

1.45

0.97

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

275

1.35

0.96

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.80

0.96

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

165

1.46

0.96

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

141

1.49

0.94

1.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.61

0.93

1.2

1.1

mg/l

13.5

10.2

0.47

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

756

0.81

0.92

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

286

1.33

0.92

1.0

1.1

—

37.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

992

1.17

0.91

1.2

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.14

0.91

2.3

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

117

1002

1.17

0.91

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

232

2085

1.11

0.89

2.0

1.9

titre

1.2

6.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

501

1.24

0.89

1.1

u/ml

4.2

10.6

2.03

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

125

1079

1.16

0.88

1.1

1.3

mmol/l

2.0

0.01

118

1018

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.91

0.88

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

783

0.82

0.87

1.6

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

110

942

1.17

0.87

1.9

1.4

umol/l

63.5

68.7

—

(3022670) pH of Venous cord blood

2.00

0.87

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.82

0.85

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1044

9960

1.05

0.85

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

622

1.21

0.85

1.1

1.2

—

(4035726)

1068

11180

0.95

0.85

1.3

1.4

—

(3006598) pH of Arterial cord blood

1.94

0.84

1.2

1.1

—

(3007733) Chloride [Moles/volume] in Urine

1.94

0.84

1.0

1.3

mmol/l

92.7

82.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.78

0.84

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

515

1.22

0.83

2.2

2.6

au/ml

177.2

144.6

0.21

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

817

1.18

0.83

1.9

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.61

0.81

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

135

1538

0.88

0.81

1.7

1.6

mmol/l

8.9

7.5

6.47

947

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.0

—

130.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.79

0.0

5.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.82

0.79

1.0

1.2

mmol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.67

0.78

2.8

2.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

339

0.74

0.78

2.5

2.9

ng/l

77.0

108.8

0.76

169

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

234

0.68

0.77

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

1.43

0.76

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

115

1.48

0.76

1.4

1.2

—

(3014891) Appearance of Pleural fluid

107

1.50

0.76

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

218

1977

1.10

0.74

1.1

1.0

u/ml

0.3

0.5

0.49

405

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.60

0.74

1.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

150

1.40

0.73

1.0

u/ml

0.1

0.2

0.10

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.00

0.72

1.0

1.2

mg/l

1.6

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.67

0.72

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

598

1.19

0.72

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

979

1.14

0.71

2.3

2.8

e6/l

992.9

750.0

1.70

413

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.55

0.71

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.92

0.70

1.0

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

203

1.33

0.70

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.79

0.66

2.2

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.51

0.66

1.1

u/l

11.8

11.7

0.00

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

128

1.41

0.65

1.1

1.2

umol/24h

2.3

1.7

0.82

128

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

267

2465

1.08

0.65

1.1

au/ml

21.5

10.8

0.37

174

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

171

1.35

0.65

1.4

1.3

62.8

57.2

0.23

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

154

1.36

0.64

1.0

u/ml

0.3

2.5

0.46

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

322

1.24

0.64

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

671

1.16

0.64

1.6

2.1

u/l

200.4

198.8

0.10

665

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

269

1.26

0.63

1.1

u/ml

0.7

1.9

0.45

188

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.52

0.62

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.52

0.62

1.5

—

(3022475) Manganese [Moles/volume] in Blood

101

0.59

0.62

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.63

0.62

1.3

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

726

6944

1.05

0.60

1.7

1.4

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.60

0.0

1.8

—

8.5

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.58

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.51

0.58

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

245

2269

1.08

0.58

1.1

u/ml

3.9

4.5

0.22

105

936

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

410

1.20

0.57

1.9

1.6

au/ml

117.3

132.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

127

1143

1.11

0.55

1.6

1.4

nmol/l

20.8

32.0

6.82

108

1050

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

133

1.35

0.54

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

243

2257

1.08

0.54

2.6

3.5

u/ml

722.7

590.7

0.15

223

2071

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

294

1.22

0.53

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

294

1.22

0.53

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

367

1.20

0.53

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

134

1.34

0.52

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

117

1.37

0.52

1.4

1.2

mmol/l

4.8

5.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

152

1.32

0.52

1.0

u/ml

0.0

0.4

0.90

111

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

545

1.16

0.51

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

135

1.33

0.51

1.4

1.3

mmol/l

0.4

1.6

1.49

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

109

1.38

0.50

1.1

u/l

19.1

22.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

876

1.12

0.50

1.3

pmol/l

67.8

100.2

0.44

274

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

103

1146

0.90

0.49

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

171

1.29

0.49

1.2

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

444

0.83

0.49

1.3

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

189

1.27

0.49

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

155

0.71

0.48

1.5

1.2

mmol/l

7.9

7.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

512

1.15

0.47

2.1

1.9

mg/l

7.4

9.6

2.46

413

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

299

1.20

0.47

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

299

1.20

0.47

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

365

1.18

0.45

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

347

1.18

0.45

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

165

1.27

0.44

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

112

1.34

0.44

4.2

4.3

g/mol

40.9

52.1

0.28

101

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

1011

1.10

0.42

1.0

u/ml

0.7

1.8

1.03

213

(40761995) Spermatozoa Progressive [#/volume] in Semen

218

0.78

0.42

3.0

2.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.56

0.42

1.0

mmol/l

8.2

4.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.29

0.41

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

397

1.16

0.41

1.6

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.52

0.41

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.52

0.41

1.8

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

217

0.78

0.41

6.0

5.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

1575.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

510

1.14

0.41

2.1

2.4

nmol/l

143.9

155.2

0.42

441

(3044316) Mercury [Moles/volume] in Urine

0.00

0.40

0.0

2.2

—

9.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.40

0.0

2.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.39

0.40

1.5

1.3

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

123

1.30

0.40

1.1

—

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.29

0.40

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.39

3.1

6.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

288

1.18

0.38

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

142

1.27

0.38

1.1

1.0

u/ml

0.0

0.5

1.18

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.38

1.6

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

270

2847

0.95

0.38

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

181

0.77

0.38

1.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

345

1.16

0.37

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

243

1.19

0.37

1.3

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

299

1.17

0.37

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

725

0.90

0.36

1.0

ng/l

232.1

369.9

1.86

526

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.43

0.35

1.8

2.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.40

0.35

1.8

2.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.33

0.33

12.3

8.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

118

1.27

0.33

1.0

u/ml

0.1

0.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

730

0.90

0.33

1.0

ng/l

33.3

40.9

1.23

519

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.68

0.33

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.28

0.32

1.2

1.0

—

(3007463) Buprenorphine [Presence] in Urine

1.35

0.32

7.2

5.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

856

1.09

0.32

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

110

1.27

0.31

1.1

—

(3042631) Mycobacterium sp identified in Specimen

151

1418

1.07

0.31

2.1

2.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

727

0.91

0.31

1.0

ng/l

877.3

743.3

1.67

511

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

211

1.19

0.31

2.2

2.8

mg/l

138.8

22.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.30

0.30

1.3

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2962

29267

1.01

0.30

4.2

4.5

ug/l

1.6

2.8

6.49

2613

26556

(3014133) Dog dander IgE Ab [Units/volume] in Serum

254

2426

1.05

0.30

1.1

u/ml

6.9

4.6

0.41

100

932

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

175

1.20

0.30

2.1

1.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

111

1.26

0.30

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

860

1.08

0.29

1.2

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

260

0.85

0.29

1.5

1.6

—

(40758358) Immune stain study

1.23

0.29

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

497

1.11

0.28

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.23

0.27

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.26

0.26

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.28

0.26

1.1

u/ml

0.1

3.9

0.67

(3030313) Adrenal Ab [Titer] in Serum

169

1.18

0.25

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.25

0.25

1.2

2.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.25

0.25

1.1

—

21.6

—

(3000012) Reticulocyte production index

570

1.09

0.24

1.5

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.71

0.24

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

233

0.86

0.23

1.2

2.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

342

1.11

0.22

1.3

1.4

65.8

61.1

0.38

283

(3001893) Eosinophils/100 leukocytes in Pleural fluid

285

1.12

0.22

1.2

1.4

1.2

2.9

1.58

243

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.76

0.22

1.3

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

297

2874

1.03

0.22

1.3

ug/l

3.7

3.4

0.29

273

2572

(3034092) Cytoplasmic Ig cells/100 cells in Blood

167

0.84

0.21

3.6

7.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

14.8

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.16

0.21

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

252

2435

1.04

0.20

1.1

u/ml

2.1

3.0

1.50

1293

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

267

2758

0.97

0.20

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

267

2756

0.97

0.19

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

300

0.90

0.18

1.7

2.1

ug/l

2.3

3.2

0.38

179

(3036071) Salmonella sp Ab [Titer] in Serum

503

1.07

0.17

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

195

1.13

0.17

6.0

7.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.22

0.17

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

332

3404

0.97

0.17

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

173

0.87

0.16

2.7

1.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.16

0.16

1.8

ng/l

170.3

180.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

130

1.15

0.15

1.1

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.76

0.15

4.8

4.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

264

1.10

0.15

1.0

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

749

0.95

0.15

2.7

2.8

44.7

40.2

0.75

262

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.12

0.15

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

188

1.12

0.14

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.08

0.14

1.7

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

181

1755

1.03

0.14

1.8

1.7

titre

1760.0

1397.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

179

1.12

0.14

1.4

1.2

mmol/l

1.3

1.8

0.98

103

(3020874) Milk IgE Ab [Units/volume] in Serum

107

1029

1.04

0.13

1.0

1.1

u/ml

0.7

1.5

0.88

255

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

714

0.95

0.13

1.3

78.0

66.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

648

1.05

0.12

5.6

6.1

u/ml

47.3

6286.7

—

127

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

127

0.87

0.12

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

114

1.14

0.11

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

269

1.08

0.11

1.9

1.3

—

(4133840)

373

0.94

0.11

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.16

0.11

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

145

1.10

0.09

1.3

3.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

124

0.89

0.09

1.7

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

341

1.06

0.08

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

656

1.04

0.08

1.5

1.6

iu/ml

3111280.2

1809259.3

—

(21494434) Karyotype in Bone marrow

915

1.03

0.07

1.1

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.08

0.07

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

225

1.07

0.07

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

975

0.97

0.07

1.3

g/l

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

273

2768

0.99

0.07

1.6

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

176

1729

1.02

0.07

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

934

0.97

0.07

5.2

6.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

452

1.04

0.07

2.4

1.9

u/ml

10770.0

8823.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

539

0.96

0.07

1.0

1.1

ng/l

384.2

476.7

—

114

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

295

0.95

0.06

1.0

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

518

0.97

0.06

1.4

2.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

246

1.06

0.06

1.5

4.7

u/l

61.5

71.7

0.14

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

454

1.04

0.05

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

135

1373

0.98

0.05

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.05

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

643

1.03

0.05

1.1

—

(40765096) Chromosome analysis panel by Banding

323

0.96

0.05

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

327

1.04

0.05

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

347

1.04

0.04

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

595

0.97

0.04

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

486

1.03

0.04

3.3

4.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

785

1.02

0.04

1.6

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

115

1166

0.99

0.03

1.7

2.3

38.2

43.5

0.89

174

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

439

1.03

0.03

1.3

1.2

14.9

20.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.09

0.03

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

289

0.97

0.02

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

810

1.01

0.02

2.3

2.7

e9/l

0.3

0.4

0.16

790

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

511

1.02

0.02

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

113

1.06

0.01

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

143

1.05

0.01

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

154

1.04

0.00

3.6

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

176

0.97

0.00

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

160

1.00

0.00

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

163

0.98

0.00

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

133

0.98

0.00

1.6

1.5

—

(3019174) dRVVT (LA screen)

146

1.03

0.00

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

483

0.99

0.00

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

415

0.99

0.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

940

1.00

0.00

1.0

u/ml

0.2

1.1

0.75

116

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

221

1.00

0.00

1.2

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

143

0.98

0.00

1.2

1.4

6.8

10.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

408

1.00

0.00

1.4

1.9

—

(44806071)

196

1.02

0.00

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

430

1.00

0.00

3.0

3.4

—

(3020650) Glucose [Presence] in Urine

395

0.99

0.00

1.4

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.2

—

(3013762) Body weight Measured

1.00

0.00

1.0

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.01

0.00

1.1

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.98

0.00

1.5

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.97

0.00

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.6

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.2

—

(3023006) Beef IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.3

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.0

—

12.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.88

0.00

1.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.219 [1.99, 2.48]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.862

During the follow-up period (1.1.1998 — 31.12.2019), 3644 out of 40743 females with E4_OBESITYNAS died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYNAS	2.399 [2.16, 2.66]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.032

During the follow-up period (1.1.1998 — 31.12.2019), 4004 out of 24666 males with E4_OBESITYNAS died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYNAS.

N-year risk	Females	Males
1	0.233%	0.497%
5	1.528%	2.936%
10	3.373%	7.02%
15	6.864%	13.363%
20	11.998%	22.102%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYNAS – Obesity, other/unspecified

GWS hits: 32

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints